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ABSTRACT
During mitosis, interphase chromatin structures change dramatically to allow formation of
discrete chromosomes. The mechanisms that follow, allowing rapid and reproducible reestablishment of functional interphase organizations, remain elusive. Our laboratory identified
locus-specific condensation differences (referred to as differential accessibility [DA]) in
metaphase chromosome homologues by visualizing genome sequence-defined single-copy (sc)
DNA probes using fluorescence in situ hybridization (FISH). Original identifications of DA
loci were performed with individual scFISH probes (1.5–4kb) in lymphocyte chromosomes.
In this study, we computationally designed multiple adjacent scFISH probes for 6 different DA
loci and determined that DA occurs in domains. Domain lengths varied from ~16kb-130kb.
DA was also investigated in other cell types (bone marrow and fibroblast samples) using 5
known DA probes and found to be maintained. DA is a conserved, structural feature in
metaphase chromosomes that may play a role in the maintenance of chromosome memory
from parent to daughter cells.

Keywords: Mitosis, human metaphase chromosomes, homologs, chromatin accessibility,
single copy DNA probes, chromosome condensation, epigenetics, topologically associated
domains, lymphocytes, fibroblasts, bone marrow, fluorescence in situ hybridization, chromatin
structure
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LAY AUDIENCE SUMMARY
Human DNA is organized into 23 different pairs of chromosomes. One member of each
pair is inherited from each parent. Chromosome structure changes from being dispersed and
string-like during periods of cell growth to highly compacted individual units during cell
division. During the compaction phase, important functional structures disappear, however,
chromosomes must return to their string-like form to function properly for cell growth. These
changes in structure are necessary to form healthy daughter cells identical to the parent cell.
This cycle continues for each new generation. The memory that allows this cycle of accurate
chromosome reorganization from one cell generation to the next is not well understood.
Highly compacted chromosomes can be seen using a microscope and individual pairs
of chromosomes can be identified. Our laboratory examines different regions of compacted
chromosomes using a technique called FISH (fluorescence in situ hybridization) that identifies
short regions of DNA by colouring the targeted region with fluorescence using DNA
probes. Using FISH with short, unique human DNA probes, we previously identified novel
non-random structural differences within individual compacted chromosomes pairs. Within a
chromosome pair, using these DNA probes, particular regions of one chromosome of the pair
shone brighter than the other. We refer to this finding as differential accessibility
(DA). Identified in white blood cells in short individual regions on multiple chromosomes, DA
results from different amounts of compaction at the same region between members of a
chromosome pair.
In this study, new DA regions were identified. Six regions were expanded to include
neighbouring, unique DNA sequences to determine if DA extended past the edges of regions
identified by one probe. DA was found to extend outside of these individual regions. Five
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regions investigated in blood, bone and skin cells showed DA to be conserved at the same
locations across the three tissues. This supports DA as a structural feature of compacted human
chromosomes present during cell division that spans beyond the edges of individual unique
regions at the same location in different cell types. DA may help to accurately transmit the
memory of important structures between parent and daughter cells.
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Chapter 1: Introduction
1.1 Introduction
The blueprint of life exists within the sequence of nucleotide bases in DNA. The 3-dimensional
organization of that sequence, both spatially and temporally, is required for proper execution
of this blueprint1. Structural organization, an essential epigenetic mechanism, regulates
differential gene expression programs required for processes such as cell growth, division,
differentiation and survival1–3. Chromatin organization achieves two purposes: fitting the entire
genome in a readily accessible manner within a spatially restrictive nucleus and allowing the
interaction of genes and distant genetic elements like promoters and enhancers as needed4. A
continuous cycle of condensation and decondensation causes dynamic chromatin organization
throughout a cell’s lifetime. A high degree of condensation is necessary to ensure high fidelity
segregation during cell division, however a more relaxed chromatin organization is required
for proper access of regulatory and transcriptional machinery to the genome to ensure normal
cell function during interphase3,5. Despite constant changes in organization through the cell
cycle, new generations of cells are able to re-establish correct gene programming consistent
with that of parent cells6. The understanding of this mechanism remains incomplete, though it
is proposed as an epigenetic memory that allows correct replication of genome organization in
cell progeny1.
Our laboratory identified a novel, non-random, stable condensation difference between
homologous metaphase chromosomes in human lymphocytes7,8. This difference is designated
differential accessibility or DA7,8. It was detected by fluorescence in situ hybridization (FISH)
using short, single-copy (sc) DNA probes7,9,10. It is not understood why DA is present in
metaphase chromosomes and if there is a relationship between DA in metaphase homologues
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and the chromatin structures present in interphase. Further investigation is necessary to address
what purpose DA may have. This study examines the genomic distribution of DA beyond
single scFISH probe boundaries to define lengths of contiguous DA intervals and assesses
whether DA is conserved across different tissues.

1.2 Higher-Order Chromosome Structures
A well-defined cell cycle is followed to produce new healthy, functional cell generations. This
cycle splits the diploid parent cell into two identical diploid daughter cells11. The cell cycle
involves complete replication and equal segregation of the genome between two daughter cells,
as well as the distribution of cytoplasm and organelles between the two. There are 4 stages in
the typical cell cycle: G1, S, G2, and M phases. Interphase includes i) G1, the phase where the
diploid cell is metabolically active and preparing for DNA replication, ii) S, the phase where
DNA is replicated, and iii) G2, the phase following replication where the cell is metabolically
active and preparing for cell division (M phase)11. M phase or mitosis, in which the parent cell
divides into 2 daughter cells, passes through a sequence of stages; prophase, metaphase,
anaphase and telophase, respectively6,12. The events describing each stage include defined
changes in chromatin condensation12–14. Metaphase is the stage in which chromatin is at its
most condensed and when discrete chromosomes can be visualized using microscopy12,13. An
incredible amount of condensation in metaphase chromosomes, which is >100 fold compared
to that of interphase chromatin, is necessary for the accurate segregation of discrete metaphase
chromosomes between daughter cells during mitotic cell division5,14–16 Once M phase is
complete, the two daughter cells are separated by cytokinesis, enter G1 and the cycle begins
again.
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The chromatin organization present in interphase must be lost during mitosis to allow
the formation of compact chromatin units5,14. To understand chromatin structure during cell
division and the methods of maintaining interphase organizations between cell generations,
knowledge of metaphase structure must be paired with knowledge of the interphase structures
lost and faithfully re-established in future cell generations1,13. Chromatin at a lower compaction
level is relatively well understood; with chromatin organization beginning with the association
of architectural proteins with the DNA strand creating a “bead-on-string” chromatin fiber
(Figure 1.1)6,17. The same cannot be said for higher-order organization of both interphase and
metaphase chromatin5,13,14,18,19. Higher-order structures organize chromatin into defined
locations, domains, and compartments that are spatially programmed in the nucleus of the
interphase cell (Figure 1.1). These locations are important to facilitate and anchor interactions
across and between chromosomes. They are involved in regulating transcription spatially and
temporally during interphase. These include an important level of organization, topologically
associated domains (TADs)6,20–22.
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Figure 1.1: Organization of chromatin during interphase from linear DNA to higherorder chromatin structures and chromosome territories to fit the genome into the
nucleus. At the nucleosomal scale, organization of the DNA strand begins by wrapping around
histone octamers to form nucleosomes. This is followed by formation of chromatin loops,
organizing into topologically associating domains then further into active A and inactive B
compartments at the supranucleosomal scale. At the nuclear scale, chromatin is organized into
chromosome territories. The increasing levels of organizations allow the genome to fit into the
nucleus. Reprinted from Ref [23] copyright licensed under a Creative Commons Attribution
4.0 International License https://creativecommons.org/licenses/by/4.0/legalcode.
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1.2.1 Chromatin Organization during Interphase
Chromatin is defined as the string of nucleic acids with the associated architectural proteins
that allow organization beyond the linear DNA sequence. The basic level of chromatin
organization are nucleosomes, eight histone proteins wrapped twice by DNA (Figure
1.1)13,17,23,24. The prevailing belief of chromatin organization has been a uniform polymer of
nucleosomes. Formed by an average 147 bp of DNA wrapped around a histone octamer, each
nucleosome is linked by a linker histone, H1, to 20-60 bp of unassociated DNA17,24. This forms
the 10nm diameter “bead-on-string” fiber that is considered the base of chromosome
organization throughout the cell cycle13,23. This histone octamer core is composed of two H3
and two H4 histone subunits forming a tetramer, and 2 heterodimers made up of one H2A and
one H2B histone13,17,23. At this level of organization there are a number of modifications with
important regulatory functions applied to both the DNA strand and histones. These include
chemical modifications such as methylation and acetylation to the common histone subunits
as well as different structural histone variant substitutes23,25.
The next level of condensation has been referred to as the 30nm strand, in which the
10nm fiber folds to form a strand of chromatin 30nm in diameter decreasing accessibility to
the underlying DNA sequence18,26,27. Two different methods of folding into this strand have
been proposed. The “solenoid” model, where the strand wraps around itself in a helical manner
with adjacent nucleosomes in contact with each other. The other is the “zigzag” model, where
nucleosomes are in contact with every other nucleosome, not with the one directly beside it,
forming a zigzag pattern18. Chromatin was believed to continue to fold in a hierarchical manner
into uniform strands of larger and larger diameters to allow the level of condensation observed
in interphase and beyond into metaphase13.
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New evidence contradicts this hierarchical folding pattern. It proposes that the base
chromatin strand is not a uniform 10nm fiber but rather a strand varying in diameter (5 – 24
nm) with a heterogeneous composition of varying nucleosome arrangement, chromatin
concentration densities and conformations13. This was observed in both resting and mitotic
cells13. There is also disagreement about the organization of the 30nm fiber and whether it
occurs in vivo19,28. Data describing both the 10nm and 30nm fiber were primarily observed in
controlled in vitro environments with low ionic concentrations and controlled histone
concentrations13,18. Further investigations across different eukaryotic organisms and the use of
computational models suggest, rather than a distinguishable 30nm fiber, interphase chromatin
is organized by the irregular folding of the base chromatin fiber into higher-order chromatin
structures18,28. Irregular folding of a less rigid 10nm stand is more consistent with reports of
chromatin dynamics during interphase that facilitate accessibility to the DNA strand, compared
to the dynamics of a less flexible uniform 30nm strand2,18,28,29.
Though there is debate over defined diameters of hierarchal chromatin organization,
there is no doubt that there are other gradations of chromatin organization formed by different
layers of chromatin structure that have been observed and studied6,21,23,30. It is clear that the
way in which higher-order chromatin structures are formed is important to the proper
regulation of cell functions6,30. These higher-order structures include chromosome looping,
topologically associated domains (TADs), chromatin compartments, and chromosome
territories (Figure 1.1)6. TADs specifically are of interest as they have been proposed as the
basic unit of chromatin folding30.
The organization of chromatin into discrete domains was initially observed during
investigations into DNA replication timing30–32. Replication sites, on average a megabase in
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length, were identified by 2 independent groups in 2 different cells types. In both studies, these
domains were preserved through multiple cell divisions30–32. Similar domain structures were
subsequently identified, using new chromatin confirmation capture technologies developed to
examine chromatin structure22,23,33,34. These methods, including 3C, 4C, 5C, and Hi-C, hold
chromatin interactions in time by chemically-crosslinking interacting segments of genome and
are used in both genome-wide and targeted analyses23. Independent studies identified patterns
of chromatin domains where contact was largely restricted within areas of 220kb-1Mb in
length with an average length of 880kb using Hi-C and 5C respectively22,33. These domains
were also conserved through multiple cell divisions and between different cell types and were
found to be consistent with the replication timing domains22,33,35. These domains have been
discussed using multiple names: topologically associated domains, topological domains, and
contact domains30. We will refer to the domains as TADs (topologically associated domains)
for further description in this thesis.
TAD boundaries are conserved across cell types and species, and are stable throughout
cell division21,22,33. They have been identified in both human and mouse embryonic stem cells,
as well as a number of pluripotent and differentiated cell types22,33. Due to this broad level of
conservation, TADs are considered a basic organizational unit of interphase chromatin
structure30. TADs are broadly defined as genomic regions where there is a high frequency of
interaction within the boundaries of a given TAD, but little interaction with adjacent
compartments and other chromatin beyond the boundaries of an individual TAD. This can be
simplified as self-association and insulation properties22,30. There is an inner TAD framework
of varying chromatin organizations. These inner structures compartmentalize interactions
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within the greater TAD structure, they include chromatin loops and sub-TAD interactions21,22.
It is these internal organizations that vary between different cell lineages21,30.
Beyond being a basic organizational unit of chromatin, TADs have been implicated in
regulation of transcription and DNA replication timing. TADs serve as both structural and
functional compartments of chromatin that bring together promotors and enhancers with both
single and multiple gene targets21,22,33. This allows co-regulation of different genetic elements
by the same regulatory elements within a single TAD. This action is predominantly isolated to
regulatory elements and genes within the TAD itself 21,30. The TAD boundaries act to contain
the action of these regulatory elements within the individual structural compartment21,22. The
boundaries are enriched with insulator proteins. One key protein is CCCTC binding factor
(CTCF), which is a zinc-finger containing DNA binding protein. CTCF is one factor with a
role in facilitating chromatin loop formation including the chromatin loops and sub-TAD
interactions on the interior of a TAD21,22. Beyond TADs, interphase chromatin is arranged into
A/B compartments6,36. These large compartments are often multiple megabases in length. They
are independent of TAD formation and are more associated with active and repressed
chromatin marks rather than structural organization of chromatin interactions6,23. The A
compartments are correlated with active transcription and open chromatin; and the B
compartments are characterized by decreased transcriptional activity and corresponding
repressing epigenetic marks20,23. These have been compared to conventional descriptions of
chromatin accessibility with respect to euchromatin and heterochromatin. Euchromatin is
associated with loosely organized chromatin with increased accessibility allowing active
transcription and is observed in metaphase chromatin as light Giemsa staining bands.
Heterochromatin is considered more highly condensed, is associated with low transcriptional

9
activity, and is visualized by dark Giemsa staining bands of metaphase chromatin37,38.
However, it is not known to what extent this metaphase conformation and interphase A/B
compartment correspond5,14. The organization into the A/B compartments are cell type
specific21,36. All of these higher levels of chromatin organization and function, including TADs
and A/B compartments, are lost as the chromatin enters the mitotic phase of the cell cycle and
condenses to form discrete chromosomes for cell division5,14.
1.2.2 Organization of Chromatin into Metaphase Chromosomes during Mitosis
Discrete chromosomes are required for faithful and complete genetic propagation in future cell
generations produced during cell division. This requires chromatin to undergo a high degree
of condensation with extensive reorganization of interphase structural arrangements3,13. The
predominate theory had been that this condensation occurred in a hierarchical manner. The 10
nm and 30 nm diameter strands, discussed in Section 1.2.1, continue to fold over itself into
strands of increasing diameters: 120 nm [i.e chromonema], 300-700 nm [i.e chromatid], and
1400nm [i.e metaphase chromosomes]13. This model, however, much like the organization into
uniform 10 and 30 nm strands primarily observed in purified chromatin in vitro, has been
challenged by recent findings of chromatin organization in vivo5,13,14. The manner in which
mitotic chromosomes organize and their internal conformation have largely remained a
mystery. A number of models, including different loops-on-scaffolds and hierarchical models,
have been proposed using a variety of methods including conventional light and electron
microscopy5,13. Recent work examining metaphase condensation and chromatin structures with
chromatin capture technologies (Hi-C, 5C)5 as well as electron microscopy tomography with
a fluorescent labeling technique in situ13 have improved understanding of mitotic chromosome
structure.
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During mitosis, similar to proposed irregular organizations of interphase, chromatin
appears to have a heterogeneous structural conformation, rather than a fiber of a consistent
diameter as the hierarchical model would suggest. The diameter of the chromatin strand was
found to cover the same range as the strands in interphase, 5 nm to 24 nm in diameter5,13,14.
The method of compaction greatly increases density of chromatin by increasing the number of
chromatin interactions, with a collapse into arrays of small compact loops around a central
axis. It is proposed that it is this density of compaction that differs between interphase and
metaphase organizations not the base organization of the strand itself

13,14

. Recent evidence

supports a loop extrusion model as the general mechanism of mitotic chromosome formation,
specifically a 2-state loop extrusion model has been proposed (Figure 1.2)5,14,39.
This model begins upon entrance into prophase with the formation of consecutive
chromatin loops extending from a central axis allowing linear compaction, followed by axial
compression. The reorganization of higher-order chromatin organization continues in
metaphase with 80 - 120 kb linear chromatin loops emitting from the central axis primarily
composed of topoisomerase IIα and condensins (Figure 1.2)5,14. A nested loop structure was
later determined, with the 80-120 kb loops forming within larger 200 - 400 kb loops during
prometaphase, evidence of which was observed in vivo and supported by polymer modeling
(Figure 1.2)14. Axial compression is achieved by the twisting of the central axis into a helix,
compressing the length of looped chromatin formation from the longer strand observed in
prophase into the short rods of metaphase14. The formation of this structure is largely mediated
by condensin I and II, condensin I is required for the inner loop structures and condensin II for
both the larger loops and twisting of the central axis into a helix (Figure 1.2)14,39. A member
of the structural maintenance of chromosomes (SMC) family of protein complexes, condensin
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is formed by 5 subunits39,40. It has been determined that one of its functions is creating
chromatin loops in an ATP dependent manner. This mitotic organization appears to be
consistent between cell types5,14.
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A)

B)

Figure 1.2: The progression of chromatin compaction during mitosis to achieve discrete
metaphase chromosomes with supercoiling differences occurring between metaphase
homologues. A) Pathway of chromosome condensation from interphase into mitosis proposed
by Gibcus et al.14. Condensin II (red) begins compaction of chromatin by forming consecutive
loops around a central axis of condensin and topoisomerase II. In prometaphase, condensin II
mediated-loops continue to increase in size. A nested loop structure is produced as condensin
I (blue) begins to form smaller more peripheral loops of the elongating condensin II mediated
loops. The central axis twists into a helical structure that allows axial compression from
prometaphase to mature metaphase chromosomes. Image reprinted from Reference [14] with
permission from AAAS (Appendix II).
B) Working model of localized differences in solenoidal supercoiling producing differential
accessibility (DA) within homologue pairs based on topoisomerase II studies (see Section 1.4)
as proposed by Khan, Rogan, and Knoll, 20158. Homologue A shows less compaction
compared to homologue B at the same loci. Compaction differences occur within individual
chromatin loops without altering loop size and frequency between homologues. Reprinted
from Reference [8], copyright licensed under a Creative Commons Attribution 4.0
International License. https://creativecommons.org/licenses/by/4.0/legalcode.
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A consequence of this reorganization is a loss of higher-order chromatin structures
observed during interphase2,5. The organization of chromatin into the compartments and
domains outlined in Section 1.2.1 are crucial during cell stages of growth and development6.
They all serve important roles in regulating accessibility of transcription factors to underlying
functional sequences allowing active transcription6,30. Distinct functional compartments and
TADs though present in interphase are not preserved during mitosis and is also accompanied
by the disassociation of a number of architectural proteins and transcription factors12,14. These
structures are no longer present by late prophase, with condensins helping facilitate this loss
of architecture while assembling chromatin in their mitotic organization, stopping transcription
for the duration of mitosis. The mechanism controlling this loss is still unknown14. However
following mitosis, during entry into G1 phase, there is a quick restoration of functional
interphase chromatin structures, re-association of lost epigenetic modifications as well as
correct transcription and regulatory activity41,42. It is known that there exists some form of
memory of previous epigenetic configurations including organizational domains, histone
modifications and protein binding sites that allows a quick restoration of these features
following cell division to ensure correct function within the new cell generation42,43. The main
focus of epigenetic memory has been the rapid restoration of transcription following exit from
mitosis and into the G1 phase of interphase. Preservation of certain histone modifications and
transcription factors have been shown in a process called genomic or mitotic bookmarking41–
44

. The variety of factors and mechanisms involved in the bookmarking process still remain

unclear including memory of interphase chromatin structures needed when re-establishing
functional interphase organization in the next cell generation42,43.
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1.2.3 Mitotic Memory and Bookmarking
Overall, mitosis corresponds with a global decrease in transcription42,45,46. This is due to
dissociation of transcription factors and their targeted inactivation and degradation
accompanied by a global change in histone modifications45,47. A significant reorganization of
overall chromatin structure with the loss of functional structures including TADs5,14 also
occurs. This reorganization also includes modifications to nucleosome structure and position
to block interactions with transcription factors14,46. However, in order re-establish the
functional chromatin structures and modifications required for transcription in daughter cells
there must be some system in place to act as a memory of the parental cell’s genomic
organization of transcriptional and regulatory signals. The identification and characterization
of mechanisms of mitotic memory and bookmarking is an ongoing investigation, of which
most details remain unknown.
Currently, the conservation of chromatin organization between generations has been
proposed to occur in both an active and passive manner48. Investigations have begun to propose
and identify mechanisms of active transmission, however passive methods remain undefined48.
Active mechanisms concern regulatory factors. More specifically described as mitotic
bookmarking, it is the conservation of regulatory factors or their specific position through
mitosis. This includes transcription factors and epigenetic modifications on mitotic chromatin
that allow the faithful inheritance of regulatory information from parent to daughter cells42,44,48.
Histone phosphorylation, for example, a modification to histone structure that occurs in mitosis
that is reversed following re-entry into interphase, has been linked to aiding in proper
chromatin condensation as well as speculated to mark gene regulatory elements25,49. Another
histone modification, H3K27ac, well characterized in interphase, is also maintained during
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mitosis in a locus-specific manner44,50. Some sites are maintained between different cell types,
reported at the promoters of housekeeping genes, and some differ between cell types, observed
at enhancers of more cell-type specific genes44. A number of transcription factors have been
identified to remain bound to mitotic chromosomes, however the nature of this retained
association, if they are occurring in a binding site specific or non-specific manner, is not clear42.
These include factors such as FoxA1, involved in liver differentiation, CTCF, an important
factor in chromatin architecture, and GATA1, an important factor in haematopoiesis42,43.
Mitotic bookmarking is thought to not only transmit structural and regulatory information to
daughter cells, but also to be involved in the rapid reactivation of transcription which occurs
upon re-entry into interphase. Thereby, maintaining positions at specific enhancers and
promotors to jump start housekeeping and cell-type specific functioning as soon as mitosis is
complete42,44. It is important to note that if a particular factor is to be considered a mitotic
memory or bookmark, evidence of the disruption in daughter cell function, structure, or
viability following interference with that factor during mitosis will need to be established48.

1.3 Chromosome Organization and Disease
In addition to aberrant coding regions in the genome that are involved in various
mechanisms of disease, there are also disruptions in non-coding regions implicated in
abnormalities as severe as those in coding regions51,52. These non-coding regions are necessary
for normal cellular function. When linking abnormal phenotypes to their underlying genetic
causes, the first area inspected is structural rearrangements that disrupt the genetic sequence
within genes. This includes point mutations, deletions, duplications, inversions, and
unbalanced rearrangements51,52. There are, however, aberrant phenotypes that cannot be linked
entirely to disruptions in coding regions of genes. Recently attention has been directed towards
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mutations and variants in non-coding regions that disrupt the functional chromatin structures
needed for normal cell function51–53. Disruption of these chromatin organizations necessary for
proper regulation of coding regions have been linked to aberrant phenotypes51–53.
Chromatin organization is a key epigenetic regulator of genes. Rearrangements that
interfere with the specific architecture of these higher-order chromatin structures, including
changing or eliminating TAD boundaries, are implicated in aberrant expression and abnormal
phenotypes51,52. As previously mentioned, TADs are considered a functional unit of chromatin,
allowing the interaction of regulatory elements with their gene targets and insulating those
genes from action of other regulators acting outside the boundaries of a given TAD.
Elimination of CTCF binding sites at TAD boundaries was found to cause the merging of
neighbouring units, and result in nontypical interactions and aberrant transcription in both
human cells and mouse models33,54. The clearest examples of TAD disruption causing
abnormal phenotypes are those rearrangements modifying the boundaries of the TAD
containing EPHA4 and its two neighbouring TADs. Alterations of these boundaries resulting
in ectopic gene regulation have been implicated in aberrant development51. Large deletions of
multiple CTCF binding sites as well as other mutations (including deletions, inversions and
duplications) occurring at TAD boundaries resulted in abnormalities of limb development in
mouse models51. The abnormal phenotypes resulting from each structural rearrangement in
mice corresponded with those observed in human samples derived from individuals with limb
malformations including brachydactyly, syndactyly, and polydactyly51. Similar disruptions of
TAD boundaries causing ectopic gene expression from abnormal interactions between genes
and distant enhancers have been associated with other limb development abnormalities as well
as neuropathies55–57.
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Beyond topologically associated domains, there are also other changes in chromatin
structure related to other abnormal phenotypes. For example, association of chromatin with the
tau protein, one of the proteins accumulated in the brain of Alzheimer patients, is connected
with widespread chromatin remodeling at the level of higher-order chromatin structure58. This
study was conducted focussing on H3K9ac, a marker of open chromatin, with tau showing a
broad effect on histone acetylation in the brain58. Connections have also been made between
the aberrant regulation associated with cancer and the reorganization of TAD boundaries3,52.
Changes in the epigenome are not restricted to single cell generations. Abnormal TAD
boundary locations and other epigenetic changes affecting the action of enhancers and
promoters will be maintained through mitosis.

1.4 Localized Regions of Differential Chromatin Condensation between
Homologous Metaphase Chromosomes
A novel, stable, and heritable difference in chromatin condensation between homologous
metaphase chromosomes in humans was first identified in our laboratory using single-copy
probe technology combined with fluorescence in situ hybridization7–10. Initially observed as a
difference in fluorescence probe intensity between metaphase homologues, it was designated
as differential accessibility (DA), after the observed difference in probe intensity was
determined to be a localized difference in chromatin supercoiling between metaphase
homologues7–10.
1.4.1 Initial Observation of Differential Accessibility (DA) – Development of Single-copy
Fluorescence in situ Hybridization (scFISH) Technique
Single-copy (sc) probe technology, first described in 2001, is a method of using the human
genome sequence to design and develop nucleic acid probes for any unique sequence region
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present9. This method excluded repetitive sequences during the design and development of the
probes9. Sc probe technology can be used with FISH or other genomic technologies to examine
the genome with high definition. ScFISH probes range in length from ~1.5 to 5 kb. Their
precise genomic coordinates are known and they can be designed to target single-copy regions
within genes, including introns, exons, and promoters, as well as in intergenic regions9. In
contrast, traditional FISH probes span much larger genomic targets (~100 kb to several
megabases), contain repetitive sequences, and are not precisely defined by genomic
coordinates9,59,60. ScFISH probes can visualize much smaller genomic regions with greater
granularity7,9. Initial scFISH studies focused on targeting clinically relevant areas of the
genome and concentrated on genes disrupted in cytogenetic abnormalities of interest9,10.
During scFISH probe validation, a difference in probe fluorescence hybridization
intensities between homologues was first observed in a minority of probes. At the time, no
clear factor, including chromosome morphology and probe characteristics, could be attributed
to causing this difference in intensity10.
1.4.2 Characterizing DA Between Metaphase Homologues
The first investigations determined that the characteristic difference in hybridized probe
fluorescence intensity between metaphase homologues was due to a distinct difference
between the chromatin condensation at the same loci7,8. Differential accessibility (DA), was
determined to be a stable, non-random, localized, and parentally-derived difference in
metaphase chromatin supercoiling between homologous pairs7,8. DA was observed in the
majority of cells ("2/3) in samples from multiple individuals and at multiple loci7. Our
laboratory has identified these localized condensation differences between homologues in
~10% of >300 scDNA probes mapped in the human genome, many of which had been
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intentionally designed to interrogate copy number and contextual changes in cytogenetically
and clinically relevant regions of the human genome7,9,10. Probes that show DA were found to
cover exonic, intronic and intergenic genomic regions7.
DA is stable, and was observed at the same loci across multiple individuals on multiple
regions across the genome7. Common copy number variants (CNVs) on homologues were
excluded as the source of the fluorescent intensity differences by comparing the genomic
coordinates of DA probes to the genomic locations of CNVs observed in two normal control
populations7. The qualitative analyses of hybridized cells identified with DA or equivalent
accessible (EA) homologues at a given locus were supported by quantitative analyses using
gradient vector flow analysis (GVF)7,61. DA loci had significantly higher average differences
in fluorescence signal between homologues than EA loci7.
Super resolution 3D structured illumination microscopy (3D-SIM) provided clear
evidence that DA resulted from a significant difference between homologues in the volume
and depth occupied by the probe. EA loci had no significant accessibility differences between
homologues7. In addition, examination of open chromatin marks present in EA and DA loci
identified a measurable reduction in open chromatin marks in DA regions compared to EA
regions7. The open chromatin marks measured were: deoxyribonuclease I hypersensitivity
(DNase I HS), formaldehyde-assisted isolation of regulatory elements (FAIRE) analysis,
histone 3 lysine 4 methylation (H3K4me), histone 3 lysine 9 acetylation (H3K9ac), histone 3
lysine 27 acetylation (H3K27ac), and histone 3 lysine 4 dimethylation (H3K4me2)7. Overall,
the levels of all open chromatin marks in DA intervals were significantly lower compared to
EA intervals7.
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The non-random and heritable localization preference of the more accessible (brighter)
hybridization to one homologue over the other was determined using samples from individuals
with homologues that could be distinguished from each other7. The observation of DA was
determined to be independent of the presence or absence of the chromosomal heteromorphism
or abnormality differentiating the homologues7. When all probe targets were considered, the
more accessible allele tracked with one parental-derived homologue within an individual,
independent of the presence or absence of the abnormality, though between individuals it could
track with either the maternal or paternal homologue. There also appeared to be a preference
to parental origin of the more accessible hybridization between generations in the same
pedigree7. This is unlike genomic imprinted loci, specific loci in which the same single parent
allele is preferentially transcribed while the other is silenced across individuals7,62.
Another strong source of evidence for a biochemical basis for DA came from treating
lymphoblast cell lines with different reagents that targeted chromosome condensation through
different epigenetic factors8. Only inhibition of topoisomerase IIα with ICRF-193, an inhibitor
of the ATPase activity that stabilizes the enzyme in an ineffective closed conformation,
affected the presence of DA at a given probe locus8,63. The inhibition of topoisomerase IIα
implicated differences in chromatin catenation levels between homologues as the basis for DA,
with a decreased amount of chromatin supercoiling of both homologues when inhibited,
equalizing the accessibility between homologues. The effects of topoisomerase IIα were
confirmed by 3D-SIM and GVF8.
All observation and characterization of DA was completed in human metaphase
chromosomes derived from lymphocyte and lymphoblast samples7,8. However, other
preliminary investigation in our laboratory suggested DA also occurred in fibroblasts.
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Intriguingly, there has also been potential evidence of DA reported from a FISH gene mapping
study recently conducted on chromosome 2 of metaphase onion root spreads 64. There were no
repetitive elements within the probe64. This suggests that DA may also be present in metaphase
chromosomes of other organisms.
All the studies completed up to the present have shown DA to be a stable, non-random
difference in chromatin catenation between homologues that is heritable between cell
generations7,8. This results in a difference in chromatin supercoiling between homologues
creating the difference in accessibility observed. Current evidence supports a potential role for
DA to distinguish between homologous regions during metaphase by accessibility of
chromatin. We suggest that DA could be a manifestation of structural memory that contributes
to maintaining information of interphase chromatin structure in these regions. In this way, a
direct link can be made between the chromatin organization of parent and daughter cells during
cell division7,8. The ability to re-establish functional structures present in interphase but lost
during metaphase is crucial to maintain correct gene regulation and cell functioning3,42. The
presence of DA has only been examined in peripheral lymphocytes and lymphoblasts with
some suggestion it may be present in other tissues as well as the genomes of other
organisms7,8,64. The specific role of DA in chromosome condensation, mitotic memory or other
possible nuclear functions, remains to be determined.

1.5 Study Objectives
The observation and characterization of DA implicates an exciting new avenue in the
investigation into chromatin structure, leading to questions involving both the observed
metaphase structure and the possible corresponding structures in interphase. The initial DA
studies showed the source of the difference in hybridized DNA probe fluorescence intensity
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between homologous metaphase chromosomes was due to differences in chromatin
superhelicity at the same loci between homologues. This present study’s objectives set out to
address both expanding knowledge about how DA is distributed throughout the genome and if
it is present in cell and tissue types besides differentiated lymphocytic cells. The previous
studies were achieved using scFISH probes designed from genomic regions of clinical
cytogenetic interest in which various pathological rearrangements were already known. These
scFISH probes were widely dispersed throughout the genome, with most only confirming DA
within the genomic coordinates of individual sc probe boundaries. This led to the question:
Does DA expand beyond the boundaries of these scFISH probes occupying larger genomic
areas i.e. what is the extent of each domain of DA chromatin?
In addition, all published data concerning DA were collected by analyzing
chromosomes of peripheral lymphocytes and lymphoblasts from multiple individuals. This
prompted the second research question: does DA occur in other tissue types or is it specifically
present only in T-lymphocytes and Epstein-Barr virus (EBV) transformed lymphoblast cells?
My hypotheses were:
1)! Differential accessibility, DA, is a structural feature of metaphase chromatin that
extends beyond the original scFISH intervals that were previously investigated in our
laboratory. In analyzing intervals adjacent to confirmed DA regions the size of DA
domains can be determined.
2)! DA is unrelated to normal tissue specific chromatin structural programming and
therefore will be conserved across the same loci in different cell and tissue types
(lymphocytes, bone marrow, fibroblasts).
To address my hypotheses, 3 specific aims were identified:
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Aim 1a: Examine genomic length and frequency of DA domains by developing scFISH
probes between and adjacent to confirmed DA regions to map size and frequency of
DA domains.
Aim 1b: Examine potential interphase features related to DA in metaphase including
epigenetic marks present in intervals exhibiting DA compared to regions demonstrating
EA using publicly available epigenetic data.
Aim 2: Determine if DA is present and maintained at the same loci across different cell
and tissue types using scFISH techniques. Cell types examined will include bone
marrow samples to examine lymphocytes at various stages of differentiation and skin
derived fibroblasts to examine cells from a different germ layer.

It is becoming more and more apparent that gathering knowledge of chromatin
structure and its organization through time and space is essential to properly understanding
gene regulation and normal cell function1. This includes how it is maintained through multiple
cell generations. DA is a new structural feature of metaphase chromatin of which little is
known, including what its role is during cell division. Further characterizing the way in which
DA is distributed in the genome as well as the different cell types in which DA is found, will
advance knowledge of in situ metaphase chromosome structure at high resolution. The
approach proposed here may also indicate possible connections to chromatin organization in
interphase. Each of these are key elements required to address the broad question regarding the
purpose of a difference in accessibility between metaphase homologues.
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Chapter 2: Materials and Methods
2.1 Design and Development of Single-copy DNA FISH probes
Single-copy (sc) DNA sequence intervals from the human genome with either no repetitive
elements or highly divergent repetitive sequences (>20%), were selected to develop scFISH
probes as previously described9,65. Each sc interval was precisely defined by specific human
genome coordinates and ranged in length from ~1.4 – 4 kilobases (kb) in length. The area to
which an scFISH probe hybridizes is interchangeably referred to as a locus, region or interval.
To develop a probe, the sc interval needed to be amplified from human genomic DNA with
polymerase chain reactions (PCR) optimized for long products, the amplicon purified, and
labelled with a modified nucleotide prior to performing scFISH on metaphase chromosomes.
The labelled probe was detected with a fluorescent antibody during scFISH.
2.1.1 Oligonucleotide Primer Design and Amplicon Production
Primer pairs for each selected sc interval were designed using Primer-BLAST66. Sc intervals
were identified using both RepeatMasker (UCSC Genome Browser) and CytoVA
(CytoGnomix Inc, London ON). The DNA sequence (hg19/GRCh37 genome assembly) for
the full sc interval was the PCR template used to generate all primer pair options. The sequence
was obtained from the UCSC Genome Browser67. Generally, 15-20 primer pairs were designed
for each sc interval. The maximum length of the PCR product was the length of the sc interval
in base pairs (bp) and a minimum length of 200-500 bp less than the maximum. The selected
primer melting temperature (Tm) range was 58.0°C - 65.0°C, with an optimal Tm of 62.0°C.
The maximum Tm difference between a pair of primers was limited to 2°C. Primer pair
specificity was verified using the “RefSeq representation genome” database for alignment with
the human genome by BLAST! (Basic Local Alignment Search Tool)68. The coordinates of
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the primer pairs were reported from the hg38 genome assembly, therefore the “view in other
genomes” option in the UCSC genome browser was used to convert coordinates to the hg19
assembly. The primer pair that was selected minimized the self-complementarity of individual
primers in the pair as well as the Tm difference between the pair. Primers in which the PCR
product had unintended targets were avoided as well as those beyond the 40 – 60% GC content
range. Longer primers were preferred (>25 bp).
Common copy number variants were also excluded from the intervals to rule out any
downstream fluorescence intensity differences between homologous regions produced by
common chromosomal polymorphisms (" 1% of the population), such as deletions and gains,
following the protocol from Khan et al. 20147. Independent microarray datasets, Ontario
Population Genomics Platforms (n= 873 individuals of European ancestry; minimum 25 probes
per CNV, Database of Genomic Variants), and Healthy sample set (n = ~400 individuals;
minimum 35 probes per CNV, Affymetrix, Inc), were used to identify common CNVs using
ChAS (Chromosome Analysis Suite) software on ThermoFisher (formally Affymetrix, Inc)
CytoScan HD array. From each single-copy interval lacking common CNVs, DNA probes
were developed and produced to both define DA domains and examine presence of DA
between tissues.
Primer pairs were then synthesized by Integrated DNA Technologies, Inc (Toronto,
ON). Amplicons of unlabeled sc probe were produced by scaling up optimized PCR reactions
for long products by 26x (fold). A 1x reaction includes the following: 3.25 µL each of the
forward and reverse primers (2µM), 1 µL of 30 ng/µL genomic DNA (Promega Corporation,
Madison WI) with 5 µL of hot start DNA polymerase (Kappa HiFi; Roche) and bringing the
volume to 25 µL with autoclaved nano water. A long PCR program was run on a gradient PCR
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thermocycler (Eppendorf vapo.protectTM Hamburg, Germany). The extension temperature was
optimized for each probe, temperatures ranged from 63°C - 72°C. The time added to each
extension for cycles 15-33 was also optimized. The general PCR parameters used to produce
the amplicon of all sc intervals are given in Table 2.1.
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Table 2.1: PCR cycling parameters for single-copy probe amplification using long PCR.
Amplification Stage
Initial Denaturation

Temperature
94 °C

Time
4 min

Cycle 1-14
Denaturation

94°C

20 sec

Extension
Cycle 15-33
Denaturation

Optimized for each probe (62 5 min
°C -72 °C)
98°C

20 sec

Extension

Optimized for each probe 5 min with a +15 sec or
+30 sec extension
(62°C -72°C)
added to each cycle.
Optimized for each
probe

Annealing

72°C

10 min
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A 0.85% (w/v) agarose gel in 1x TAE buffer (Tris-acetate-EDTA buffer) was used to
check the result of the amplification to ensure that the amplicon produced was uniform and of
the correct size. For those amplifications that synthesized the expected product, amplification
was followed by ethanol precipitation of the amplicons in a volume of 3 M sodium acetate
equal to 0.1 x PCR reaction volume and a volume of cold anhydrous ethanol equal to 2.5 x
PCR reaction volume. Amplicon was precipitated for a minimum of 12 hours at -20°C. The
GeneAid Gel/ DNA PCR extraction kit (New Taipei, Taiwan) was used to purify the amplicon
after separation of products by length using gel electrophoresis with 0.85% low melting point
agarose gel (Avantor; A426-05) submerged in 1x TAE buffer. The final concentration of
purified amplicon was measured using a NanoDrop 2000 spectrophotometer (ThermoFisher
Scientific, Waltham MA). Figure 2.1 shows an example of an optimal (left) and poor (right)
probe amplicon purification gel. The two lanes for TPM1_F2294 show the desired high
concentration of amplicon (identified by size) with minimal banding above and below the band.
This is compared to an amplification of 3.3_1p36, a probe designed for a known EA region,
with smearing visible below the band of amplicon. Extraneous DNA overlaying the desired
amplicon can be a potential source of background in FISH and complicate or prevent analysis.
This probe was later re-optimized to eliminate the undesired amplification products causing
the smear.
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Figure 2.1: Gel image example of an optimal and poor scFISH probe amplification
produced in this study. TPM1_F2294 (left) provides an example of an optimal amplification,
2 lanes with bands of high probe concentration, with little smearing above and below band of
probe. 3.3_1p36 (right), is an example of a probe from this study that was re-optimized due to
smearing below the desired amplicon. Extraneous amplifications pose a risk for non-target
hybridizations causing high background and inhibiting analysis of metaphase chromosomes.
Amplicon was run on a 0.85% TAE agarose gel in 1x TAE buffer. Gel is stained using
InvitrogenTM SYBRTM safe (ThermoFisher) and visualized using UV light. Ladder is 1Kb
RTU from Froggabio (Toronto, ON) and size units are in bp.
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2.1.2 Labeling of Purified Amplicon by Nick Translation
All amplicons were labeled with digoxigenin-11-dUTP (Roche Diagnostics, Indianapolis, IN)
by nick translation as described by Knoll and Lichter in Current Protocols in Molecular
Biology69. Nick translations were performed at 15°C. The nick translation reaction to label 1µg
of purified amplicon (5-20µL) in a final volume of 100uL was: 10 µL of a nick translation
solution [working solution of 0.2mM of dATP, dCTP, and dGTP, 0.1mM of dTTP (Roche
Diagnostics), 0.5M Tris-HCl pH 7.8, 2.86 M 2-mercaptoethanol (Millipore-Sigma), 0.1 µg/
mL bovine serum albumin (Roche Diagnostics) and varied concentrations of MgCl2 dependent
on the DNA polymerase I manufacturer], 4 µL of DNA polymerase I (5 units/µL ), 5µL of
100mM digoxigenin -dUTP (Roche Diagnostics) with 5 µL of a 5:1000 5µg/µL DNase I
dilution (Worthington Biochemical, Lakewood, NJ), and sterile high quality water to the final
volume of 100 µL69. The MgCl2 concentration within the nick translation solution varied
depending on the DNA polymerase I storage buffer composition of the manufacturer. DNA
polymerase I from the Promega Corporation required 0.2M MgCl2 in the final 100µL nick
translation reaction volume whereas DNA polymerase I from Roche Diagnostics required
0.05M MgCl2 for optimal activity. The DNase I dilution was optimized for each new batch
received from the manufacturer.
The enzymes for the nick translation reactions were calibrated so that the amplicon was
digested to 250-750 bp in length over 150 minutes (Figure 2.2). After digestion, a 15µL aliquot
of the reaction was removed to check the size of the nicked products by gel electrophoresis.
Before loading the reaction onto the gel, the reaction was stopped by adding 1.5µL of 0.5M
EDTA, pH 8 and incubated at 70°C for 5 minutes. The remainder of the reaction was stored at
-80°C until the size was confirmed. If the size was optimal, the reaction was stopped with 2
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µL of 0.5M EDTA, pH 8 and incubated at 70 °C for 5 minutes as done with the test aliquot. If
the probe was too large, the reaction was placed at 15 °C for additional time and/or additional
enzymes were added. After labelling, the probe was ethanol precipitated (same method
described for the precipitation of amplicon), lyophilized to dryness and reconstituted in 10µL
of sterile nanopure water for a final concentration of 0.085µg/µL. Labelled amplicon was
stored at -20 °C until use for fluorescence in situ hybridization (FISH).
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Figure 2.2: Example image of check gel to assess length of nick translation products of
3.3_1p36, ONECUT1_F2701, and XDH_C2501 probes. All lanes with labeled probe show
the desired length of probe between 250 – 750 bp. The labeled amplicon was run on a 0.85%
TAE agarose gel in 1x TAE buffer. Gel is stained using InvitrogenTM SYBRTM safe
(ThermoFisher) and visualized using UV light. The ladder, on the left, is 1Kb RTU from
Froggabio (Toronto, ON), and the size units are in bp.
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2.1.3 Probe Nomenclature System
Nomenclature for probes under validation followed a different naming convention than fully
validated probes. Multiple single-copy intervals were identified within large suspected DA
regions detected by a literature review of historical FISH gene mapping studies predating
completion of the human genome project. Therefore, new probes were named by the gene
target of the mapping study and the letter corresponding to the individual single-copy interval
within the suspected DA region with the length in base pairs of the probe separated by an
underscore (ex. XDH_C2501). Gel images of probes maintain this naming convention as
probes were still undergoing optimization and validation protocols.
Validated probes were given names more descriptive of their individual position within
the genome. They were named as follows:
Intergenic: Coding gene closest to probe interval (longest RefSeq isoform)_
position of probe relative to gene (centromere[cen] or telomere[tel]) plus
distance in base pairs between nearest boundary of the gene and that of the
probe (ex. RBM38_tel25076).
Within gene: Gene _ interval of exons and introns spanned by the probe
following Human Genome Variation Society (HGVS) conventions70
(ex. TPM1_IVS5-IVS8).

2.2 Probe Selection to Determine DA Domain Size
The DA regions selected to address the genomic length and frequency of DA intervals and to
classify DA domains were identified during development of a systematic method for
identifying new regions of DA across the genome rather than focussing on regions relevant to
clinical syndromes7,9,10,71. This was achieved by a PubMed search and review of images in
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publications with human genes or genomic sequences mapped to chromosomal bands on
metaphase chromosomes using FISH71. Publications were not selected based on areas of
clinical significance but rather by gene mapping studies with published FISH images. These
historical gene mapping studies contributed to the assembly and completion of the human
genome sequence.
The published FISH images were examined for visual differences in fluorescence
intensity of hybridized probes between homologues. Those probes that appeared different were
categorized as potential DA regions for further characterization in the laboratory71. These
probes used in the historical gene mapping studies72–77 were large human genomic sequences
that ranged in size from 50kb to several hundred kb, cloned into vectors such as cosmids or
BACs. The precise genomic sequences of these large probes were not known. In contrast,
scFISH probes have much shorter targets, generally ranging in length from 1.2- 4.0 kb, their
precise genomic sequence and coordinates within the human genome are known and are not
generally cloned. To confirm if the suspected DA regions were true DA or EA, the candidate
region was established using the gene target of the historical probe as a genomic anchor and
extending both upstream and downstream of the anchor by the reported length of the historical
probe. This produced the overall genomic region from which scFISH probes were developed
using the method outlined in Section 2.1.
Multiple single-copy intervals were identified across each candidate genomic region
and probes were developed as described above. Candidate genomic regions with a successful
hybridization of 2 different single-copy intervals, both of which demonstrated DA, were
selected to be investigated further. Interpreted as contiguous DA domains, these are areas of
the genome where multiple DA intervals are identified in close proximity within the same
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region. Single-copy FISH probes were designed adjacent to the confirmed DA loci. The
identified domains were XDH (2p23), HMGB1P5 (3p24), FGF6 (12p13), TPM1 (15q22),
COX5A (15q25), and HMGB1P1 (20q13). Domains were named using the target of the
original gene mapping study that identified the candidate region.

2.3 Probe Selection to Examine if DA Occurs in Different Tissues
A set of probes that demonstrated DA in lymphocyte or lymphoblast cells were selected to
determine if DA was conserved across bone marrow and fibroblasts. All probes representing
both DA and EA intervals were selected from our archive of previously validated probes. DA
intervals present within genes (intronic and exonic) as well as in intergenic intervals, were
selected from to establish DA across different tissues in both gene coding and noncoding
intervals. To avoid confounding factors such as differential tissue expression, sc probes within
genes were selected with no to low expression (0.0 – 5.0 transcripts per million [TPM]) across
all tissues of interest (lymphocytes/blasts, bone marrow, fibroblast).
Due to the large file sizes generated from whole transcriptome sequencing, the
identification of expression values from only specific genes with known DA and EA intervals
and only within selected tissues of interest was achieved by a Python script (Appendix III)
written to accelerate the search. The script searches publicly available RNA expression data
generated across different tissues and reports mean expression values for selected genes. The
script was run separately for DA and EA intervals within genes. Expression data were
downloaded from the Genotype-Tissue Expression (GTEx)78 and Human Protein Atlas79,80
databases. Expression data were reported in transcripts per million (TPM). Data available from
GTEx provided expression values for EBV transformed lymphocytes and fibroblasts from
multiple samples representing each tissue; the script calculated the mean and standard
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deviation across these samples78. Results for bone marrow were obtained using data from
Human Protein Atlas of which data were reported as mean expression values for each gene in
each tissue79,80.
DA probes were selected according to the following criteria:
a) localized within a gene
b) gene showed no/low expression (0.0–5.0 TPM) in the different cell types analyzed
c) probe hybridized well in lymphocytes (low background, good hybridization
intensity/efficiency)
Two DA probes in intergenic regions were chosen to determine if DA is also conserved
in regions where there is no gene coding. One intergenic EA probe from Khan et al. 20147 was
selected to control for a locus where DA was not observed in lymphocytes. Following the
above analysis, the probes selected were XDH_IVS30-IVS27, PCK1_cen180-IVS6, and
DUOX1_IVS1-IVS3. These probes are within the genes XDH, PCK1, and DUOX1
respectively. Intergenic DA regions selected were TPM1_tel3200 and CTCFL_cen34302.
Intergenic EA probe selected is 3.3_1p36.

2.4 Cell Culture and Preparation
Metaphase cells were identified by dropping cytogenetic methanol-acetic acid fixed cell pellets
onto microscope slides. Fixed cell pellets were obtained from blood, bone marrow, and
fibroblast samples. Fibroblast samples, specifically, were obtained from cultured cell lines.
The cytogenetic samples were derived from de-identified residual cell pellets that remained
after routine cytogenetic diagnostic procedures were completed at the London Health Sciences
Center Clinical Cytogenetics Laboratory (University of Western Ontario Office of Research
Ethics: Study #15345E; 5453). Cytogenetically normal cell pellets were used for bone marrow

37
samples. Fixed cell pellets were produced following routine cytogenetic protocols for cell
culture and harvest81,82. Specific preparation for metaphase cells included arresting cells in
metaphase by inhibiting microtubule formation with colcemid followed by inducing cell
swelling using a hypotonic solution of 0.075 M potassium chloride (KCl). Both lymphocytes
and bone marrow cells were treated with colcemid for 30 minutes. Lymphocytes were treated
with 150 µL - 200 µL and bone marrow treated with 200 µL of colcemid (stock: 10 µg/mL)
when in 10mL of medium81,82. Cells were then fixed in this state with a 3:1 methanol: glacial
acetic acid solution (Carnoy’s fixative) for preservation and storage. Lymphocytes were
stimulated with phytohemagglutinin (PHA) 48-72 hours prior to arresting in metaphase81.
Cytogenetic preparations were also prepared from control fibroblast samples derived
from epidermal biopsy83. These samples were obtained by Dr. Knoll prior to arriving at the
University of Western Ontario and stored in liquid nitrogen. Fibroblasts were grown in 8mL
of DMEM – Dulbecco’s Modified Eagle Medium (Gibco; 11960-044) supplemented with 15%
heat-inactivated

fetal

bovine

serum

(FBS)

(Hyclone;

SH30396.03)

and

1%

penicillin/streptomycin (Hyclone; SV30010) in a T25 flask at 37°C/5% CO2 until they reached
~70% confluence for metaphase cell harvest. Medium was replenished every 3-4 days and
changed 24 hours prior to harvest.
Harvesting protocol followed The AGT Cytogenetics Laboratory Manual. Fibroblast
cells were arrested in metaphase with Karyomax! colcemid (Gibco; 15212-012) for 4 hours
at a ratio of 10 µL of 10 µg/mL colcemid per 1 mL of medium. To maximize the number of
mitotic cells, two cell fractions were collected: i) the mitotic fraction of rounded cells following
colcemid treatment in the culture medium ii) the fraction of cells (metaphase and interphase)
that remain attached to the tissue culture flask. The first fraction was collected by transferring
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the culture medium into 15mL conical polypropylene tubes. The second fraction was collected
after treating the remaining attached cells in the T25 flask with 4mL of trypsin-EDTA (0.05%),
Phenol-red (Gibco; 25300-062) incubated at 37°C until cells were detached from the flask wall
(~3 minutes). The trypsin was inactivated by adding an equal volume of DMEM medium
supplemented with FBS. Each fraction was spun at 400 x g in a bench-top clinical centrifuge.
The supernatant was removed, and the pellets combined in 15mL conical polypropylene tubes.
Cells were resuspended in 5 mL of 0.075M hypotonic pre-warmed KCl solution followed by
incubation at 37°C, for a total of 25 minutes (including resuspension and incubation times).
Following incubation, a partial fixation of the cells was performed. Two mL of 3:1 methanol:
glacial acetic acid solution was slowly added (6-12 drops a time with gentle mixing) to the
5mL of KCl solution with cells. This was followed by centrifugation, removal of the
supernatant and two complete fixations of the cell pellet using the same fixative.

2.5 Single-copy Fluorescence in situ Hybridization (ScFISH)
The single-copy probes selected and prepared as described in Section 2.1 were used in
fluorescence in situ hybridization where sc probes were hybridized to metaphase cells and
detected with a fluorescently labeled antibody. The FISH protocols from Knoll and Lichter,
and Rogan et al. 2001 were followed with some modification to washing steps9,69.Cell
preparations with spread metaphase cells on glass microscope slides were denatured at 70°C
in 70% deionized formamide/2X saline-sodium citrate (SSC) solution for 2 minutes. Slides
with denatured cells were then immediately dehydrated for 2 minutes each in 70% ethanol (on
ice), 80%, 95% and 100% ethanol. Slides were then left to air dry at room temperature until sc
probe hybridization solution was prepared.
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For one slide, 150-200 ng of dig-11-dUTP labeled scDNA probe, 11µL of deionized
formamide (Biobasics; FB0211) and 1µL of C0t-1 DNA (1 µg/µL; Roche Diagnostics) were
combined in a 0.5 mL sterile microcentrifuge tube and denatured at 70°C for 5 minutes. The
probe mixture was placed at 39°C for 30 minutes then combined with an equal volume of
hybridization buffer solution (working solution: 10% w/v sterile dextran sulfate, 2mg/mL
nuclease free bovine serum albumin (BSA) (Roche Diagnostics) and 4x SSC). The complete
volume (~22µL) was applied to a 22mm2 region of cells on each slide and covered with a
22mm x 22mm plastic coverslip. The slides were sealed in a parafilm pillow and placed in a
dry incubator at 38°C overnight to allow hybridization of the probe with the chromosomal
DNA. The following day, the slides were washed in 3 solutions sequentially for 30 minutes
each: in 50% formamide/ 2X SSC (39°C), 1X SSC (39°C) and 0.5X SSC (room temperature)
solutions. The first two washes were shaken manually at 10-minute intervals and the third at
room temperature was agitated on an orbital shaker for 30 minutes at 100-200 rotations per
minute. The post-hybridization washes removed non-specific hybridizations and residual
hybridization solution.
The hybridized probe was then detected using Cy3-conjugated antidigoxin, an IgG
monoclonal mouse antibody (Jackson ImmunoResearch, West Grove, PA), diluted 1:200 (v/v)
in detection buffer (4xSSC with 1% BSA [filtered Cohn V. Fraction]). The hybridized region
(22mm2) on the slides were incubated in the dark with 50 µL of Cy3-conjugated antibody for
45-60 minutes at room temperature. Three post-detection washes followed, consisting of 0.5X
SSC, 0.5X SSC/0.3% Triton-X 100 (Millipore-Sigma), and 0.5X SSC for 20-30 minutes each
on an orbital shaker. The cells were stained with 50 µL of 4’,6-diamidino-2-phenylindole
(DAPI, 0.1 µg/mL phosphate buffered saline), in the dark for 20-40 minutes, followed by a
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brief rinse in McIlvaine buffer (0.1M citric acid, 0.2M disodium phosphate; pH 7.2). Slide
preparations were then mounted in 7 µL of antifade84 (1mg 1,4 phenylenediamine per 1mL of
sterile glycerol [FisherBioreagents; BP229-1]), covered with a 22mm x 22mm No.0 glass
coverslip and then sealed with nail polish. Cells were imaged using a Zeiss epifluoresence
microscope system and analyzed as described in the next section.

2.6 Scoring of Hybridized Probe Fluorescence Intensity Differences Between
Metaphase Homologues
An AxioImager Z.2 epifluorescence microscope system (ZEISS; Thornwood, NY) with
3 optical filters (blue [DAPI], green [FITC], red [customized for Cy3]) operating with
Metasystems software, Metafer4 (V3.8.12), was used to capture metaphase images of the
labelled probe and stained chromosomes at different colour wavelengths. The filters were used
to capture DAPI blue fluorescence to visualize the staining of chromosomes and their specific
banding patterns that allow chromosome identification and Cy3 red fluorescence to capture the
Cy3 antibody labelled probes. For cell imaging, DAPI fluorescence was set for capture with
automatic exposure control while Cy3 fluorescence was captured with a fixed exposure time.
A low power scan of each slide was completed using a 10X objective (Zeiss Plan Apochromat
10X/0.45), and a subset of metaphase cells were selected by the analyst and imaged at higher
magnification (Zeiss Plan-Apochromat 63X/1.4 Oil). Metasystems Metafer software was used
to collect metaphase images. Metasystems Isis (V 5.3) package was used for manual image
review and analysis.
Evaluation of differences in the fluorescence intensity between homologues was
completed following previously reported methods of identifying DA7,8. After identification of
the chromosome and chromosome band to which a specific probe was designed to bind, the
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fluorescence intensity of the signal on each homolog was scored on an empirical scale of nil/0,
dim, medium, bright, and very bright. Chromosome identification and scoring of fluorescence
signals was completed independently by a minimum of 2 analysts. A metaphase cell was
considered to show differential accessibility (DA) if homologues were scored with different
intensities (ex. Bright/ medium, bright/dim medium/dim). A cell was scored as equivalently
accessible (EA) when homologues were scored with equivalent intensities (ex. Bright/bright,
medium/ medium). Any scores of dim/dim, nil/nil, or dim/nil were excluded to avoid
inefficient probe hybridization bias. Hybridized chromosomes involved in overlap at or near
the location of probe hybridization were also excluded as physical interference in hybridization
could also result in a difference in fluorescence intensity not derived from accessibility of
chromosome structures. For most samples, 25-75 cells were scored, and a minimum of 2
samples were evaluated per scFISH probe. For a given DA interval, a two-tailed binomial test
with normal approximation was used to determine if there was a significant difference between
the proportion of cells identified with DA compared to the proportion of identified EA cells.
As 2 different samples were hybridized per probe, a two proportion Z-test was also used to test
if the proportion of DA or EA cells of a given probe differed between samples. A cell was
confirmed to be DA or EA if there was a significant difference between the proportion of cells
identified as DA compared to EA. Both statistical tests were performed at # = 0.05.
The difference in fluorescence intensity was quantified using integrated gradient vector
flow analysis (GVF) for a subset of probes7,61. DA probes XDH_IVS30-IVS27,
ZNF385D_tel678016, DUOX1_IVS1-IVS3, TPM1_tel3200, PCK1_cen180-IVS6 and EA
probe 3.3_1p36 were selected. GVF analysis used an algorithm previously developed in the
laboratory to establish boundaries of probe signals and quantify the intensity of the signal
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within that boundary61. Using the grey-scale image of the fluorescence signal, the integrated
intensity value (pixels) was calculated within the active binary contour generated around the
signal61. To determine if there was a difference between the signals on each homolog of a cell,
a normalized intensity ratio was calculated by the following:
!"#$"%&#'()*#&+ =

|(&"#$/0*#$1(&"#$"%&#'(ℎ+3+4+/(1 − &"#$/0*#$1(&"#$"%&#'(ℎ+3+4+/(2)|
(&"#$/0*#$1(&"#$"%&#'(ℎ+3+4+/(1 + &"#$/0*#$1(&"#$"%&#'(ℎ+3+4+/(2)

Values approaching 0 indicate homologues with fluorescence signals of similar intensities and
therefore equivalent accessibility whereas values approaching 1 indicate a difference in signal
intensity indicative of DA7. A Mann-Whitney U test was used to determine if the intensity
ratios differed between the DA probes developed for this study and EA probes.

2.7 Analysis of Epigenetic Characteristics Present During Interphase for
Individual Probe Loci and DA Domains
The precise genomic coordinates of each DA and EA locus were known from the probe design
process and genomic location confirmed by scFISH in metaphase chromosomes from Tlymphocytes. This allowed the comparison of specific genomic intervals with confirmed DA
or EA classifications during metaphase with multiple interphase epigenetic characteristics
including open chromatin marks and functional higher-order chromatin structures at the same
loci. Epigenetic features characteristic of open chromatin were analyzed following the same
methods as for previously reported DA and EA probes7. Open chromatin data were obtained
from the Encyclopedia of DNA Elements (ENCODE)85 for DNase I hypersensitivity (Duke
DNase1 HS), Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) (University
of North Carolina FAIRE seq) and histone marks H3K4me1, H3K9ac, H3K27ac, and
H3K4me2 (Broad Institute histone modifications custom tracks). All open chromatin marks
reported were derived from data collected from the EBV transformed lymphoblastoid cell line,
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GM12878, in which DA had previously been characterized7. All histone modification data
were derived from ChIP-seq (chromatin immunoprecipitation assay with sequencing) signal
intensities for all probe intervals. The sum for each open chromatin mark was calculated for
each interval for all probes, and a mean integrated intensity was calculated for DA and EA
groups individually. Box and whisker plots (with the whisker limits determined by the Tukey
method) of each mark for both EA and DA were plotted. Unpaired t tests with Welch correction
for unequal variances were used to test for significant differences between the mean integrated
intensity of each open chromatin mark between DA and EA intervals (# = 0.05).
The 3-D genome browser86 was used to analyze higher-order chromatin structures,
topologically associated domains (TADs) as well as sub-TADs, present within DA intervals to
compare the presence of defined DA domains in metaphase with functional chromatin
organization in interphase. Chromatin capture data (Hi-C) collected from a genome wide study
published in 201421 were accessed using this database. Chromatin interaction frequency
heatmaps were also generated using the database and additional genomic information was
determined by integrating a UCSC (University of Santa Cruz) genome browser window67. All
data accessed were collected from experiments on the lymphoblast cell line, GM12878, with
the GRCh37/Hg19 genome assembly. The data that were generated used the Lieberman-raw
format at a resolution of 25kb. Correspondence of domains with TADs and other sub-TAD
interactions was completed visually using scaled heat-map and genome browser outputs from
the 3-D genome browser and UCSC Genome Browser respectively67,86.
TAD boundaries are characterized by the clustering of insulator proteins. CTCF is one
of the important insulators involved in defining the edges of each TAD, as well as aiding the
formation of other higher-order chromatin structures in its role producing chromatin loops. To
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investigate the clustering of CTCF protein, within and at the boundaries of TADs, an
information theory-based approach developed by Lu et al. 201787 was used to predict CTCF
binding sites within the boundaries and beyond the boundaries of each DA domain87.
Prediction of CTCF binding site loci and binding affinity were generated using information
theory-based transcription factor binding site motifs within the defined genomic coordinates
of each domain ± 1Mb. As average TAD size is ~880kb, data generated for each domain
reached into a minimum of the adjacent TADs22. Sites generated with binding affinities (Ri)
equal to or greater than half the overall mean binding affinity (Rsequence) were reported.
Within each domain the sum of binding affinities of each CTCF binding site was
calculated and normalized by dividing by the number of kilobases in each domain. Two
different classifications of areas outside of DA domains were investigated to determine if there
was a difference in strength of CTCF binding within domains compared to areas beyond their
boundaries. These were areas of equal size within the same chromosome, one area selected
beyond the boundaries of the DA domain but within the same TAD and one area selected in
the adjacent TAD to the DA domain. A Kruskal-Wallis test was used to determine if there was
a difference between the 3 groups.
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Chapter 3: Results
3.1 Identification of New Regions of Differential Accessibility (DA)
3.1.1 New Sc Probes Developed and DA Confirmed by Qualitative ScFISH on Human
Metaphase Chromosomes
All 18 sc probes (1459-3553bp) developed for this study were localized by FISH to the
expected regions in metaphase chromosomes of PHA stimulated lymphocytes of peripheral
blood (Primer details; Appendix IV). The probes ranged in size from 1459 to 3553 bp in length
and mapped to chromosomes 2, 3, 12, 15, and 20. Three of the probes, TPM1_IVS5-IVS8,
SCAMP2_IVS7-IVS4, and COX5A_tel20100 showed cross-hybridization on non-targeted
chromosomes. SCAMP2_IVS7-IVS4 had consistent hybridization on the p arm/satellite of
acrocentric chromosomes in addition to the clear hybridization of the target. TPM1_IVS5IVS8 had a cross hybridization at approximately 1q21 whereas COX5A_tel20100 had
nontarget hybridizations at the terminus of 1p and 6q in addition to a centromere hybridization
on chromosome 12. It was somewhat surprising that the BLAST! did not find any areas of
the human genome with highly similar sequences, and similarly that BLAT (BLAST-like
alignment tool) from the UCSC Genome Browser also did not predict these areas of nontargeted hybridization. The cross-hybridizations of acrocentric short arms, centromeric, and
heterochromatic regions may be related to the fact that the DNA sequence of these regions of
the genome are known to be incomplete, however the autosomal regions of cross-hybridization
were unexpected. Nevertheless, these cross-hybridizations did not interfere with the analysis
of DA.
Eighteen of these previously uncharacterized sequence intervals exhibited DA in
metaphase chromosomes. All probes developed for this study were shown to hybridize

46
according to the previously established criteria for either DA or EA patterns7. Probes
demonstrating DA showed the characteristic difference in probe fluorescence intensities
between homologous chromosomes, in contrast to one previously reported probe7 showing EA
on both homologues. Figure 3.1 shows examples of metaphase cells with differences in
fluorescence intensity between homologues for 3 DA probes (SCAMP2_IVS7-IVS4,
ZNF385D_tel678016, FGF6_IVS2) and an example of hybridization of one cell with similar
fluorescence intensity of EA probe 3.3_1p36. DA and EA regions differ significantly from
each other by the proportion of cells with observed DA. When the majority of cells ("2/3) have
a DA hybridization pattern, the probe is designated as a DA probe and similarly when the
majority of cells have an EA pattern, the probe is designated as an EA probe. A minority of
cells in each sample exhibit the opposite hybridization pattern than the probe designation i.e.
a DA probe has predominately DA hybridization patterns on metaphase cells with a small
subset with EA patterns. We evaluated the consistency of this definition of DA or EA for all
probes using a two-tailed binomial test with normal approximation that excluded the null
hypothesis i.e. the equivalent hypothesis (Table 3.1). DA probes demonstrated a significantly
higher proportion of DA cells compared to EA cells (p values $1.5E-04) across 2 samples
(Figure 3.2). EA probe, 3.3_1p36, was confirmed to have a significantly higher proportion of
cells with EA hybridizations than DA hybridizations (p = 1.4E-04, Table 3.1). This indicates
that by qualitative scoring of probe fluorescence intensity differences between homologues,
each probe developed for this study hybridized to a DA region in human T-lymphocytes.
Prior to developing the sc probes, the sc genomic intervals within the regions of interest
were determined computationally to have no or rare copy number variants (CNVs) within the
regions (Section 2.1.1). Intervals with common CNV gains or losses are quite common in
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normal and abnormal genomes of humans as well as other species. These intervals were
excluded from probe development so CNVs would not be the source of probe fluorescence
intensity differences between homologues. The frequencies of CNV gains or losses within the
sc probe genome intervals from this study are shown in Appendix V.
For each probe, metaphase cells from T-lymphocyte samples of 2 different individuals
were hybridized. Cells were scored as DA or EA as outlined in Section 2.6 and the number of
cells scored as DA and EA were totaled. Cell numbers examined for each probe hybridization
varied between samples based on mitotic index. These data are presented in Table 3.1. A two
proportion Z-test (# = 0.05) demonstrated that there was no evidence of a significant statistical
difference between the fraction of cells scored as DA between the different patient samples
(n=23) used to identify the accessibility pattern of 17 of 18 probes (Table 3.1). One DA probe,
SCAMP2_IVS7-IVS4 showed a difference (p=0.02) between the fraction of cells with DA
between samples, however both samples clearly showed DA (>2/3 DA). This may represent a
stochastic difference or be individual related. For EA probe, 3.3_1p36, there was also no
significant statistical difference found between patient samples in the proportion of EA cells
scored for each individual (Table 3.1).
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Equivalent
Accessibility

Differential Accessibility
SCAMP2_IVS7-IVS4

ZNF385D_tel678016

FGF6_IVS2

3.3_1p36

Figure 3.1: Differential and equivalent accessibility hybridization patterns between human metaphase homologues detected by
single-copy probe fluorescence in situ hybridization. Chromosomes from single metaphase cells hybridized with single-copy FISH
probes developed for the intervals SCAMP2_IVS7-IVS4 (3002 bp; 15q24.1), ZNF385D_tel678016 (2251 bp; 3p24.3) and FGF6_IVS2
(3430 bp; 12p12.3) [left to right] show differential probe fluorescence hybridization between homologues. Differential probe
fluorescence from left to right: 1 dim compared to 2 bright hybridizations, 1 bright and 1 dim compared to no hybridization, and 0
compared to 1 medium hybridization. Arrows indicate the expected location of probe hybridizations on each homologue in full
metaphase and magnified images. ScFISH probe 3.3_1p36 (3354 bp; 1p36) shows similar fluorescence intensity (or equivalent
accessibility [EA]) between homologues. Chromosomes were stained with DAPI and probes were labelled with digoxigenin-11-dUTP
and detected with Cy3-digoxin antibody.
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Figure 3.2: Frequency of cells exhibiting DA on homologous chromosome regions by sc
probe FISH analysis. The black and grey shading represent the relative proportion of cells
with DA and EA, respectively. Each row represents the results for each sc probe from samples
of 2 individuals. All probes show DA with the exception of the EA probe, 3.3_1p36 (last row).
All DA probes (n=18) had a statistically significant larger proportion (73-89%) of cells
demonstrating DA compared to one EA probe 3.3_1p36, bottom row, (24%) which had a
significantly larger proportion of EA. Significance was demonstrated using a two-tailed
binomial test with normal approximation (! = 0.05).
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Table 3.1: ScFISH probes developed and validated to evaluate the extent of DA domains established with an anchor scFISH
probe and conservation of DA between tissues. Location of each probe is indicated by chromosome band and genomic coordinates.
The number of cells scored as DA and EA per sample is indicated along with the total number of DA and EA cells scored per interval
for both samples. The p-value results are given from two proportion Z-test testing if there is a statistical difference between individuals
and a two-tailed binomial test with normal approximation testing statistical difference between proportion of DA and EA cells scored
overall for each probe.
Sample*

Probe Name

Chromosome
Band

XDH_tel9264

2p23.1

XDH_tel2387

2p23.1

XDH_IVS30-IVS27†

2p23.1

ZNF385D_tel640535

3p24.3

ZNF385D_tel678016

3p24.3

FGF6_cen4492

12p12.3

FGF6_IVS2

12p12.3

DUOX1_IVS1-IVS3†

15q21.1

TPM1_IVS5-IVS8^

Genomic
Coordinates
[GRCh37/hg19]

Length
(bp)

Genomic
Position

Differential Accessibility
chr2:31,545,815- 2110
Intergenic
31,547,924
chr2:31,551,816- 2986
Intergenic
31,554,801
chr2:31,568,769- 2501
XDH
31,571,269
chr3:22,433,351- 3968
Intergenic
22,436,333
chr3:22,470,832- 2251
Intergenic
22,473,082
chr12:4,537,157- 1660
Intergenic
4,538,816
chr12:4,5497763430
FGF6
4,553,205
chr15:45,422,890- 1708
DUOX1
45,424,597
2408
TPM1

p-value (! = 0.05)
FISH
Two
Two-tailed
1
2
Total
Pattern
proportion
binomial
Z-test
test
between
# of cells scored between
samples
DA and EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA

50
12
24
3
30
7
65
11
51
13
42
6
30
3
45
8
30

35
14
23
4
18
2
28
2
17
4
33
9
19
3
50
11
13

85
26
56
10
48
9
93
13
68
17
75
15
49
6
95
19
43

0.25

2.1E-08

0.26

1.5E-08

0.90

2.4E-07

0.27

7.8E-15

0.093

3.2E-08

0.48

6.7E-09

0.38

2.5E-10

0.67

1.1E-12

0.49

2.4E-06
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15q22.2
TPM1_IVS8

15q22.2

TPM1_tel3200†

15q22.2

SCAMP2_IVS7-IVS4^

15q24.1

SCAMP2_IVS1

15q24.1

COX5A_tel20100^

15q24.1

RBM38_tel25076

20q13.3

CTCFL_cen34302†

20q13.3

PCK1_cen13036

20q13.3

PCK1_cen180-IVS6†

20q13.3

3.3_1p36†
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7

2

9

DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA
DA
EA

31
6
19
6
49
16
27
10
25
3
36
8
32
6
18
3
31
12

52
15
36
7
44
4
40
10
35
9
27
14
20
8
49
9
18
6

83
21
55
13
93
20
67
20
60
12
63
22
52
14
67
12
49
18

DA
EA

3 10
13 28

13
41

0.60

1.2E-09

0.80

3.5E-07

0.025

6.5E-12

0.89

4.7E-07

0.63

1.5E-08

0.55

8.7E-06

0.59

2.9E-06

0.21

6.1E-10

0.28

1.5E-04

0.55

1.4E-04

* Samples 1 and 2 are from different individuals. The same samples were not used across all probes. Samples from 23 different individuals were
used for hybridizations. A minimum of one sample is always from a male.
† Probe selected to investigate conservation of DA between tissues
^ Probe showed cross-hybridization with non-target chromosomes
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3.1.2 Quantification of DA by Gradient Vector Flow Analysis (GVF) in ScFISH Probes
Gradient vector flow (GVF) analysis of integrated probe intensities was used to validate the
qualitative scoring of homologous loci7,61. This method analyzed differences between the
previously identified fluorescence intensity comparisons of the same sequences on different
homologues (none/dim, medium, bright, very bright) in metaphase images. GVF quantified the
fluorescence intensity of each probe hybridization over all pixels in each metaphase image.
From these values, an integrated intensity ratio was calculated between homologues for a
sample of cells for each probe within a subset to classify them as either DA or EA. Intensity
ratio scores approaching or equal to 0.0 indicate equivalent (or similar) hybridization
intensities between homologues whereas intensity ratio scores approaching or equal to 1.0
indicate a greater difference in probe hybridization intensities between homologues. Integrated
intensity ratio formula is provided in section 2.6.
Hybridizations of 5 DA probes (XDH_IVS30-IVS27, ZNF385D_tel678016,
DUOX1_IVS1-IVS3, TPM1_tel3200, PCK1_cen180-IVS6) and one EA probe (3.3_1p36)
were analyzed by GVF using one pair of chromosome homologues per cell for 25 cells for
each sc probe (DA n=125 diploid cells, EA n=26 diploid cells). Distributions of the normalized
integrated intensity ratios of DA and EA regions were compared in a box and whisker plot
(Figure 3.3). A significant difference (p <0.0001) was determined between the median intensity
ratio of DA (0.82) and EA regions (0.23) using a Mann-Whitney non-parametric test, after a
non-normal distribution was determined with the Shapiro-Wilk test (p<0.0001). This trend was
consistent with previous characterization of published DA and EA regions7.

53

1.0

Normalized Integrated Intensity Ratio

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
DA

EA
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Figure 3.3: Quantification of probe signal fluorescence between homologues shown by
box and whisker plots of normalized integrated fluorescence intensity ratios. The limits
of the whiskers were determined using the Tukey method for box plots. Single-copy probes
(XDH_IVS30-IVS27,

ZNF385D_tel678016,

DUOX1_IVS1-IVS3,

TPM1_tel3200,

PCK1_cen180-IVS6; n=125) detecting DA showed a large difference in hybridization
intensities between homologues relative to the single-copy probe detecting EA (3.3_1p36;
n=26). A significant difference was determined between the median integrated intensity ratio
of DA (median = 0.82) and EA regions (median = 0.23) using a Mann-Whitney U test. The
interquartile range for DA regions is 0.31 – 1.00 whereas that of the EA region is 0.07 – 0.57.
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3.1.3 Comparing Open Chromatin Marks Between DA and Equivalent Accessibility (EA)
Regions
Previous investigation into connections between previously reported DA sequences and
sequence specific chromatin accessibility marks present in interphase found that overall there
was lower enrichment of 6 open chromatin marks in DA sequences compared to EA sequences.
The same trend was observed between 17 of 18 new DA sequences from this study compared
to the 59 EA sequences previously reported7. The profiles of the same 6 open chromatin marks
(DNase 1 hypersensitivity (DNase 1 HS), Formaldehyde Assisted Isolation of Regulatory
Elements (FAIRE), and histone modifications H3K4me, H3K9ac, H3K27ac, and H3K4me2)
were compared between the new DA loci identified in this study (n=18) and the previously
characterized EA loci7 (n=59). All DA probes were investigated using integrated intensity
ENCODE data85 from interphase cells of EBV transformed lymphoblastoid cell line
GM12878. Using a box and whisker plot, a single outlier (red dot) can be observed in 5 of the
6 open chromatin marks. These points were all derived from a single DA interval,
SCAMP2_IVS1 (Figure 3.4). Only enrichment of H3K4me at this locus was within the
boundaries of the whiskers. There is a pronounced enrichment of open chromatin marks at
SCAMP2_IVS1 compared to other DA loci, both identified in this study and those previously
published7. Figure 3.5 shows an example of open chromatin mark enrichment of H3K27ac at
SCAMP2_IVS1 relative to the 2 neighbouring DA regions, SCAMP2_IVS7-IVS4 and
COX5A_tel20100. Due to this clear single point deviation from other DA loci, SCAMP2_IVS1
open chromatin mark data were removed from the other DA interval data sets prior to statistical
testing between DA and EA loci.
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Overall lower mean integrated intensities of all 6 open chromatin marks (DNase 1 HS,
FAIRE, H3K4me, H3K9ac, H3K27ac, and H3K4me2), were observed in 17 DA regions
relative to the same open chromatin marks in 59 EA regions (Figure 3.6). This is consistent
with the trend observed in previous work7.
An unpaired t-test with Welch’s correction for unequal variances identified a
significantly lower integrated intensity of DA intervals compared to EA intervals for open
chromatin marks DNase I HS (p = 0.0006), H3K9ac (p=0.0042), H3K27ac (p=0.0025), and
H3K4me2 (p=0.0070). No significant difference was identified between the FAIRE (p=
0.3232) and H3K4me (p=0.1727) marks present at DA and EA intervals (Figure 3.6).
Individual values for each open chromatin mark across all DA and EA regions investigated in
this study are found in Table 3.2.
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Figure 3.4: Distribution of integrated intensity data for each open chromatin mark in
new DA intervals (n=18) and previously reported EA intervals7 (n=59). Data are presented
in a box and whisker plot with the limits of each whisker determined by Tukey for each open
chromatin mark (x-axis). Center line of each box represents the median. Outliers are
represented by dots beyond the limits of the whiskers of each box plot. A single outlier from
the DA group identified in 5 of 6 open chromatin marks was derived from the same interval,
SCAMP2_IVS1.
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Figure 3.6: Open chromatin marks at DA loci have lower mean integrated intensities
compared to EA loci. Integrated intensity values of DA regions were significantly lower than
EA regions of DNase I HS, H3K9ac, H3K27ac, and H3K4me2 using an unpaired t-test with
Welch’s correction for unequal variances. No significant difference was found between the
mean integrated intensity values of DA and EA regions for FAIRE and H3K4me (p>0.05). The
95% confidence intervals for the DA (n = 17, excluding SCAMP2_IVS1) and previously
reported EA intervals (n=59)7 are shown.
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Table 3.2: Integrated intensity values of open chromatin marks in each DA and EA
interval from this study. Present in interphase, integrated intensity values were retrieved from
the ENCODE project85 as averaged replications from the GM12878 cell line over each DA and
EA interval identified in metaphase.
Total Integrated Intensity
Probe Name

DNase1
FAIRE2 H3K4me H3K9ac
HS1
XDH_tel9264
5797
16484
1397.64 121.64
XDH_tel2387
4172
14177
200.12
181.32
XDH_IVS30-IVS27
2685
7588
139.4
66.6
ZNF385D_tel640535 7757
16562
181.24
68.88
ZNF385D_tel678016 1508
12601
214.96
88.8
FGF6_cen4492
2201
8667
189.92
58.32
FGF6_IVS2
5924
13874
712.68
132.8
DUOX1_IVS1-IVS3
3906
9097
229.48
75
TPM1_IVS5-IVS8
2592
12419
168.68
94.12
TPM1_IVS8
4115
18354
373.2
137.96
TPM1_tel3200
4316
13824
1602.12 154.16
SCAMP2_IVS7-IVS4 2652
11393
918.52
210.28
†
15355
27321
2108.4
1589.36
SCAMP2_IVS1
COX5A_tel20100
4638
8371
1234.48 148.36
RBM38_tel25076
6082
14144
1949.36 202.28
CTCFL_cen34302
7848
20677
996.36
112
PCK1_cen13036
4225
16928
366.56
127.04
PCK1_cen180-IVS6
4323
11077
227.12
129.96
3.3_1p36
11592
8710
544.0
168.4
1
DNase I Hypersensitivity
2
Formaldehyde Assisted Isolation of Regulatory Elements
†
Data excluded from ANOVA analysis (Section 3.1.3 justification)

H3K27ac

H3K4me2

96.2
53.16
30.64
29.6
14.6
29.6
29.6
63.44
42.72
47.56
160.56
150.28
4924.44
44.4
110.44
110
44.4
42.12
115.6

403.24
51.8
22.2
22.2
37.0
143.12
143.12
25.96
29.6
115.88
478.4
111.2
1856.52
292.68
343.36
111
51.8
97.2
120.6
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3.2 Defining DA Domains in Human Metaphase Homologous Chromosomes
3.2.1 Identification of Differentially Accessible Domains
DA domains were defined as areas of the genome over which multiple single-copy regions
demonstrating DA were confirmed to be neighbouring each other using scFISH probes. Six
DA domains were identified by developing adjacent sc probes within a genomic area in which
there was a confirmed DA probe. These domains were: XDH (2p23), HMGB1P5 (3p24), FGF6
(12p13), TPM1 (15q22), COX5A(15q25) and HMGB1P1 (20q13). Domains were named for
the target of the original gene mapping study examined for which scFISH probes identifying
DA intervals were designed. The boundaries of each domain were defined by the smallest and
largest genome coordinates of the two DA probes that were the greatest distance apart from
each other. The area of a given domain is inferred to be continuous between scFISH probes.
The DA probes defining each domain are listed in Table 3.3.
The DA domains range in size from 16 kb to 129.6 kb with 2 to 4 DA regions identified
within each of these domains (Table 3.3). The XDH domain is defined by 3 DA regions and
spans 25.5 kb of chromosome 2p23.1 (Figure 3.7). Two DA regions within the XDH domain
are intergenic, XDH_tel9264 [2110 bp] and XDH_tel2387 [2986 bp], while the third region
covers intron 30 to intron 27 of the XDH gene, XDH_IVS30-IVS27 [2501 bp]. The HMGB1P5
domain is an entirely intergenic domain, found within chromosome 3p24.3. It is defined by 2
DA probes that span 39.7 kb (Figure 3.8), ZNF385D_tel640535 [3968 bp] and
ZNF385D_tel678016 [2251 bp]. The two smallest domains, FGF6 (Figure 3.9) and TPM1
(Figure 3.10), were identified on chromosomes 12p12.3 and 15q22.2, respectively. FGF6 spans
16.0 kb and is defined by 2 DA regions, one that is intergenic, FGF6_cen4492 [1660 bp], and
the other that is found within intron 2 of FGF6, FGF6_IVS2 [3430 bp]. The TPM1 domain
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also spans ~16.0 kb. It is defined by 3 DA probes. Two probes span intron 5 to intron 8 of the
TPM1 gene, TPM1_IVS5-IVS8 [2408 bp] and TPM1_IVS8 [3300 bp] and one is within an
intergenic region, TPM1_tel3200 [2294 bp]. The two largest domains are COX5A (Figure
3.11) located on 15q24.1 and HMGB1P1(Figure 3.12) located on 20q13.3. Spanning 110 kb
and 129.6 kb respectively, these domains cover large areas of genome. COX5A is defined by
2 DA regions found in the SCAMP2 gene, one spanning intron 7 to 4, SCAMP2_IVS7-IVS4
[3002 bp] and the other in intron 1, SCAMP2_IVS1 [1526 bp] and 1 intergenic region,
COX5A_tel20100 [1725 bp]. HMGB1P1 is defined by 4 DA regions. Three are in intergenic
regions, RBM38_tel25076 [2021 bp], CTCFL_cen34302 [3553 bp], PCK1_cen13036 [3533
bp] and 1 that covers just beyond the centromeric edge of the PCK1 gene to intron 6,
PCK1_cen180-IVS6 [3092 bp]. In both the COX5A and TPM1 domains, there are large areas
not covered by scFISH probes. Probe development was attempted in these areas, however a
number of constraints on scFISH probe design restricted hybridization within these prospective
regions. These included the restriction of probe design by the presence of repetitive elements
and optimization failures of prospective probes designed in these areas.
To investigate DA domains, probes from 5 different chromosomes were designed in
intervals within genes (coding regions) and in intervals within intergenic regions (non-gene
coding regions). The genomic contents as well as precise genomic coordinates of each probe
are given in Table 3.3. Within the TPM1 domain (Figure 3.8), 3 regions of DA spanned a short
distance of 16.0 kb. Within this area, 8.0 kb was confirmed as DA by sc probe hybridization.
The XDH and FGF6 domains spanned similarly small regions, 25.5 kb and 16.0 kb, with 2 and
3 DA regions defining the domains respectively. ScFISH probe hybridizations identified DA
in 7.6 kb and 5.1 kb of the XDH and FGF6 domains. The proximity of these DA regions within
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such a short span of genome suggests that differential accessibility between homologues
extends beyond the defined coordinates of a single probe and are therefore found in areas larger
than those covered by single scFISH probes (1.5-5 kb).
Demonstration of up to 4 DA intervals within 129.6 kb (HMGB1P1 domain; Figure
3.12) and 3 DA intervals within 110.0 kb (COX5A domain; Figure 3.11) suggest even larger
domain sizes. However, these larger domains may not actually cover a continuous region of
DA. In the HMGB1P1 domain, this can be observed with a large gap of 82.9 kb between the
CTCFL_cen34302 and PCK1_cen13036 loci, and smaller gaps of <25 kb between the other
probes defining this domain. This is also evident in the COX5A domain (Figure 3.11), where
3 probes span 110kb with 87.3 kb not covered by scFISH probes between DA loci
SCAMP2_IVS1 and COX5A_tel20100. However, the proximity of these regions, as well as
other domains demonstrated in this study suggest DA is a feature of metaphase chromatin
present in neighbouring single-copy regions. The location of the sc regions hybridized to define
each domain provides evidence that DA occurs more frequently within neighbouring sc
genomic intervals than was demonstrated by previously published evidence of individual DA
probes that were distributed across larger genomic intervals.
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Table 3.3: List of DA domains with each scFISH probe defining each domain.
Domain
Name
[length]

Chromosome
band

Probe Name
XDH_tel9264

chr2:31,545,815-31,547,924

Intergenic

XDH_tel2387

chr2:31,551,816-31,554,801

Intergenic

XDH_IVS30-IVS27

chr2:31,568,769-31,571,269

XDH

ZNF385D_tel640535

chr3:22,433,351-22,436,333

Intergenic

ZNF385D_tel678016

chr3:22,470,832-22,473,082

Intergenic

FGF6_cen4492

chr12:4,537,157-4,538,816

Intergenic

FGF6_IVS2

chr12:4,549776-4,553,205

FGF6

TPM1_IVS5-IVS8

chr15:63,353,573-63,355,980

TPM1

15q22.2

TPM1_IVS8

chr15:63,357,346-63,360,645

TPM1

chr15:63,367,314-63,369,607

Intergenic

15q24.1

TPM1_tel3200
SCAMP2_IVS7IVS4
SCAMP2_IVS1

chr15:75,161,783-75,163,308

SCAMP2

COX5A_tel20100

chr15:75,250,595-75,252,319

Intergenic

RBM38_tel25076

chr20:56,009,465-56,011,485

Intergenic

CTCFL_cen34302

chr20:56,033,167-56,036,719

Intergenic

PCK1_cen13036
PCK1_cen180-IVS6

chr20:56,119,569-56,123,101
chr20:56,135,957-56,139,048

Intergenic

XDH
[25 454 bp]

2p23.1

HMGB1P5
[39 731 bp]

3p24.3

FGF6
[16 048 bp]

12p12.3

TPM1
[16 034 bp]

COX5A
[109 970 bp]

HMGB1P1
[129 583 bp]

Genomic
Position*

Probe Coordinates
[GRCh37/hg19]

20q13.3

chr15:75,142,349-75,145,350

SCAMP2

PCK1

Bp = base pair
*Genomic position refers to the genetic characteristics of the sequence hybridized by each individual
sc probe. Intergenic refers to a sc probe target outside of gene coding regions. A gene name indicates
that the sc probe target is within that given gene.

64
2p23
21

chr2 (p23.1)

Scale
chr2:

31,540,000

14

31,545,000

p12

13

31,550,000

RefSeq Curated

34 35

hg19
10 kb
31,555,000 31,560,000 31,565,000
RefSeq gene predictions from NCBI

31,570,000

31,575,000

31,580,000

XDH

Repeating Elements by RepeatMasker
SINE
LINE
LTR
DNA
Simple
Low Complexity
Satellite
RNA
Other
Unknown

25.5 Kb
Location of scFISH probe hybridization

Domain area not covered by scFISH probes

Repetitive Elements

Figure 3.7: Genomic map of XDH domain. A human chromosome 2 ideogram with a
magnified view within chromosome band 2p23 (red) that contains the XDH DA domain. The
image was created within the UCSC browser67 using the GRCh37/hg19 human genome
assembly. The domain is represented by turquoise and yellow bars with adjacent chromatin
outside the domain in white. The domain size spans ~25.5 kilobases (kb) [chr2:31,545,81531,571,269]. Yellow bars indicate specific locations of the 3 hybridized scFISH probes in this
domain; left to right XDH_tel9264, XDH_tel2387, XDH_IVS30-IVS27. The left margin
indicates what is presented in each track. Genomic coordinates are provided in 5 kb intervals
followed by curated genes (RefSeq, dark blue) within the region and then multiple tracks of
different repetitive sequences. These repeating elements (RepeatMasker) are represented using
a greyscale with the lighter the grey, the higher the divergence between DNA sequences within
the same family. ScFISH probes are located within regions that either have no repeating
elements or repeating elements that have a sequence of divergence of >20%. The different
repetitive elements shown include: short interspersed nuclear elements (SINE), long
interspersed nuclear elements (LINE), long terminal repeat elements (LTR), DNA repeat
elements, simple repeats, low complexity repeats and others.
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Figure 3.8: Genomic map of HMGB1P5 domain. A human chromosome 3 ideogram with a
magnified view within chromosome band 3p24 (red) that contains the HMGB1P5 DA domain.
The image was created within the UCSC browser67 using the GRCh37/hg19 human genome
assembly. The domain is represented by turquoise and yellow bars with adjacent chromatin
outside the domain in white. The domain size spans ~39.7 kb [chr3:22,433,351-22,473,082].
Yellow bars indicate specific locations of the 2 hybridized scFISH probes in this domain; left
to right ZNF385D_tel640535, ZNF385D_tel678016. The left margin indicates what is presented
in each track. Genomic coordinates are provided in 10 kb intervals followed by curated genes
(RefSeq, dark blue) within the region and then multiple tracks of different repetitive sequences.
These repeating elements (RepeatMasker) are represented using a greyscale with the lighter
the grey, the higher the divergence between DNA sequences within the same family. ScFISH
probes are located within regions that either have no repeating elements or repeating elements
that have a sequence of divergence of >20%. The different repetitive elements shown include:
short interspersed nuclear elements (SINE), long interspersed nuclear elements (LINE), long
terminal repeat elements (LTR), DNA repeat elements, simple repeats, low complexity repeats
and others.
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Figure 3.9: Genomic map of FGF6 domain. A human chromosome 12 ideogram with a
magnified view within chromosome band 12p13 (red) that contains the FGF6 DA domain. The
image was created within the UCSC browser67 using the GRCh37/hg19 human genome
assembly. The domain is represented by turquoise and yellow bars with adjacent chromatin
outside the domain in white. The domain size spans ~16.0 kb [chr12:4,537,157- 4,553,205].
Yellow bars indicate specific locations of the 2 hybridized scFISH probes in this domain; left
to right FGF6_cen4492, FGF6_IVS2. The left margin indicates what is presented in each
track. Genomic coordinates are provided in 5 kb intervals followed by curated genes (RefSeq,
dark blue) within the region and then multiple tracks of different repetitive sequences. These
repeating elements (RepeatMasker) are represented using a greyscale with the lighter the grey,
the higher the divergence between DNA sequences within the same family. ScFISH probes are
located within regions that either have no repeating elements or repeating elements that have
a sequence of divergence of >20%. The different repetitive elements shown include: short
interspersed nuclear elements (SINE), long interspersed nuclear elements (LINE), long
terminal repeat elements (LTR), DNA repeat elements, simple repeats, low complexity repeats
and others.
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Figure 3.10: Genomic map of TPM1 domain. A human chromosome 15 ideogram with a
magnified view within chromosome band 15q22.2 (red) that contains the TPM1 DA domain.
The image was created within the UCSC browser67 using the GRCh37/hg19 human genome
assembly. The domain is represented by turquoise and yellow bars with adjacent chromatin
outside the domain in white. The domain size spans ~16.0 kb [chr15:63,353,573 - 63,369,607].
Yellow bars indicate specific locations of the 3 hybridized scFISH probes in this domain; left
to right TPM1_IVS5-IVS8, TPM1_IVS8, TPM1_tel3200. The left margin indicates what is
presented in each track. Genomic coordinates are provided in 5 kb intervals followed by
curated genes (RefSeq, dark blue) within the region and then the multiple tracks of different
repetitive sequences. These repeating elements (RepeatMasker) are represented using a
greyscale with the lighter the grey, the higher the divergence between DNA sequences within
the same family. ScFISH probes are located within regions that either have no repeating
elements or repeating elements that have a sequence of divergence of >20%. The different
repetitive elements shown include: short interspersed nuclear elements (SINE), long
interspersed nuclear elements (LINE), long terminal repeat elements (LTR), DNA repeat
elements, simple repeats, low complexity repeats and others.
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Figure 3.11: Genomic map of COX5A domain. A human chromosome 15 ideogram with a
magnified view within chromosome band 15q24.1 (red) that contains the COX5A DA domain.
The image was created within the UCSC browser67 using the GRCh37/hg19 human genome
assembly. The domain is represented by turquoise and yellow bars with adjacent chromatin
outside the domain in white. The domain size spans ~110.0 kb [chr15:75,142,349-75,252,319].
Yellow bars indicate specific locations of the 3 hybridized scFISH probes in this domain; left
to right SCAMP2_IVS7-IVS4, SCAMP2_IVS1, COX5A_tel20100. The left margin indicates
what is presented in each track. Genomic coordinates are provided in 50 kb intervals followed
by curated genes (RefSeq, dark blue) within the region and then multiple tracks of different
repetitive sequences. These repeating elements (RepeatMasker) are represented using a
greyscale with the lighter the grey, the higher the divergence between DNA sequences within
the same family. ScFISH probes are located within regions that either have no repeating
elements or repeating elements that have a sequence of divergence of >20%. The different
repetitive elements shown include: short interspersed nuclear elements (SINE), long
interspersed nuclear elements (LINE), long terminal repeat elements (LTR), DNA repeat
elements, simple repeats, low complexity repeats and others.
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Figure 3.12: Genomic map of HMGB1P1 domain. A human chromosome 20 ideogram with
a magnified view within chromosome band 20q13.3 (red) that contains the HMGB1P1 DA
domain. The image was created within the UCSC browser67 using the GRCh37/hg19 human
genome assembly. The domain is represented by turquoise and yellow bars with adjacent
chromatin outside the domain in white. The domain size spans ~129.6 kb [chr20:56,009,46556,139,048]. Yellow bars indicate specific locations of the 4 hybridized scFISH probes in this
domain; left to right RBM38_tel25076, CTCFL_cen34302, PCK1_cen13036, PCK1_cen180IVS6. The left margin indicates what is presented in each track. Genomic coordinates are
provided in 50 kb intervals followed by curated genes (RefSeq, dark blue) within the region
and then multiple tracks of different repetitive sequences. These repeating elements
(RepeatMasker) are represented using a greyscale with the lighter the grey, the higher the
divergence between DNA sequences within the same family. ScFISH probes are located within
regions that either have no repeating elements or repeating elements that have a sequence of
divergence of >20%. The different repetitive elements shown include: short interspersed
nuclear elements (SINE), long interspersed nuclear elements (LINE), long terminal repeat
elements (LTR), DNA repeat elements, simple repeats, low complexity repeats and others.
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3.2.2 Epigenetic Characteristics of DA Domains and the ScFISH Probes Defining DA
Domains – Topologically Associated Domains (TADs)
Characterisation of epigenetic structures in genomic regions corresponding to DA probe
intervals was expanded to include higher-order levels of chromatin folding related to gene
expression and regulation during interphase6,30,42. Topologically associated domains (TADs)
have been suggested to form structural units in interphase chromatin22,30. TADs facilitate
interactions with regulatory elements and their gene targets within the defined boundaries of
chromatin scaffolds. Adjacent TADs are separated by insulator sequences that isolate
interactions of regulatory elements within an individual TAD and protect from interaction of
regulatory elements outside the defined boundaries that are intended for other gene targets22,30.
Publicly available data of chromatin confirmation capture information from Hi-C analysis in
lymphoblast cell line GM1287821 was accessed and visualized using the 3D Genome
Browser86. Hi-C arrests the 3D chromatin structure of a population of cells by holding points
of contact in place across the genome, then sequencing is used to determine the frequency at
which two distinct points in the genome are within contact within that population. The Hi-C
data were used to assess the correspondence between loci of DA in metaphase and interphase
TAD structures. The 3D genome browser86 was used to visualize TADs and sub-TAD
interactions over the DA domains defined in metaphase chromosomes and the surrounding
chromatin (>100kb up and downstream) within the same TAD as well as adjacent chromatin
folding structures.
Five of the six DA domains (XDH, FGF6, COX5A, TPM1, HMGB1P1) in metaphase
chromosomes that we defined in Section 3.2.1 were each contained within a single TAD. The
other domain, HMGB1P5, was located between 2 TADs. The COX5A (Figure 3.13),
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HMGB1P1 (Figure 3.14), and HMGB1P5 (Figure 3.15) domains are presented as examples in
figures 3.13 through 3.15. The other 3 domains, XDH, FGF6, and TPM1, are presented in
figures 1 through 3 in Appendix VI.
The frequency of chromatin interactions within the TAD and in the area surrounding
each DA domain are observed in the contact frequency heat maps (red). To interpret the
frequency of contact between two genomic points, a triangle connecting the two points is
drawn and the intensity of red at the point of the peak (where the lines from the two genomic
points intersect) indicates how frequent contact is between these points. The frequency of
contact data presented were the average frequencies within the entire cell population examined.
Four of the 5 domains (XDH, FGF6, COX5A, HMGB1P1) contained within a separate TAD
show clear, high frequency, intra-TAD interactions (evidence of sub-TAD structures)
occurring between the chromatin within the DA domain and areas beyond the domain within
the same TAD. This is evident in both the COX5A domain (Figure 3.13) and HMGB1P1
domain (Figure 3.14) where there are clear triangles of high frequency sequence interactions
(bright red) above the domain with areas in close proximity within the same TAD, as well as
larger contact points connecting more distant loci within the TAD. All four domains show the
bright red associated with the highest frequency of interaction between points. This shows
domains in contact with multiple areas within the TAD during interphase. Similar observations
of sub-TAD interactions in close and distant loci of the TAD can be observed within the XDH
and FGF6 domains (Appendix VI. Fig 1 & 2).
Weaker points of contact were observable between the TPM1 domain (Appendix VI
Fig. 3) and surrounding chromatin within the same TAD. Overall the entire TAD in which the
TPM1 domain is located has few observable high frequency contacts suggesting overall weak
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contact levels. Weak intra-TAD interactions indicate that few sub-TAD structures are present
across this particular TAD in the GM12878 cell line. The lower level of contact within the
TPM1 domain is similar to the HMGB1P5 domain (Fig 3.15) which is found between the
boundaries of 2 different TADs in very close proximity to the boundary of the blue-grey TAD.
However, the observation of 5 of 6 metaphase DA domains, each within an individual TAD,
also with sub-TAD interactions is consistent with a possible link between TAD structures that
are present during interphase and regions of DA present in metaphase homologous chromatin
at 2p23, 12p13, 15q22.2, 15q24.1, and 20q13.3.
A number of architectural proteins have been implicated in the formation of TAD
structures, the most well-established connection being with CTCF insulator proteins. The
boundaries of topologically associated domains can be characterized by clustering of CTCF
binding sites21,22. Maintaining knowledge of the location of these clusters is important to reestablish functional TAD structures at the same location after their loss during metaphase.
Though all TAD boundaries are clusters of CTCF, not all CTCF binding sites are TAD
boundaries as they also facilitate chromatin looping within TADs involved in producing subTAD structures. As 4 of 6 DA domains occurred within a single TAD, with observable high
frequencies of intra-TAD interaction indicative of sub-TAD looping structures, binding of
CTCF would be required to help facilitate the formation of these structures as well as delimit
the overall boundaries of each TAD. Prediction of CTCF binding site loci and their binding
affinity were generated using information theory-based transcription factor binding site motifs
using an algorithm written and validated by Lu et al. 2017

87

. Sites generated with binding

affinities (Ri) equal to or greater than half the overall mean binding affinity (Rseq) were reported
across the genomic areas of each domain, plus and minus 1Mb.
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Within each domain the sum of binding affinities of each CTCF binding site was
calculated and normalized by dividing by the number of kilobases in each domain. Genomic
areas of equal size in kilobases within the same chromosome, one area beyond the boundaries
of the domain but within the same TAD and one area in the adjacent TAD to the domain, were
selected to determine if there was a difference in strength of CTCF binding sites within
domains compared to other areas of the genome. No significant difference (p = 0.5367) was
found between the median binding affinity per kilobase in each group using a Kruskal Wallis
test with multiple comparisons (Table 3.2). This indicates that the domains within the
boundaries defined in this study did not differ in the level of CTCF binding site affinity per
kilobase compared to areas outside the domains. This analysis does not support the hypothesis
that DA domains present in metaphase differ in CTCF binding site affinity compared to areas
outside the domains during interphase. However, this is a small sample size of domains of
which the boundaries have not been defined by adjacent equivalently accessible region;
therefore, further investigation into DA domains as a potential bookmark of CTCF binding
clusters in metaphase should not be ruled out.
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Table 3.4: Median CTCF binding affinity/kilobase across DA domains compared to
sequences of equal length beyond the boundaries of the domain within the same TAD
and in the adjacent TAD.

DA Domain
Median CTCF
binding affinity
(Rseq)/kilobase
(bp))

12.680

Location of Sequence
Outside Domain
within the same
TAD
8.262

Adjacent TAD

12.720

No significant difference between groups (p = 0.5367)

78

3.3 DA Loci Are Conserved Between Peripheral Blood, Bone Marrow, and
Fibroblast Tissues.
Three different tissue types (peripheral blood, bone marrow, and fibroblasts) were selected to
investigate the presence and conservation of DA loci across different cell and tissue types. The
cell type in which DA loci were initially identified and characterized was peripheral
lymphocytes (T-lymphocytes and B-lymphoblasts)7,8. All new DA probes designed for this
study were validated and identified in T-lymphocytes. In bone marrow, the dividing cells
represent a heterogeneous mixture of cell types including both B and T lymphocytes as well
as hematopoietic stem cells and differentiating lymphoid and myeloid cells. This allowed
investigation of DA beyond the terminally differentiated and activated lymphocytes in which
DA was characterized. Fibroblast cell samples (originally derived from skin punch biopsies)
represent different germ layers with fibroblasts derived from the ectoderm while lymphocytes
and bone marrow are derived from the mesoderm88. Preliminary unpublished work in our
laboratory suggested that DA occurred in fibroblasts.
3.3.1 Expression in DA Regions Across T-Lymphocytes, Bone Marrow Cells and
Fibroblasts
Five DA probes were selected as described in Methods section 2.3 to compare presence
of DA between the tissue types. Four of the probes were used in the domain studies previously
described. Three of the probes were within genes: XDH_IVS30-IVS27, PCK1_cen180-IVS6,
and DUOX1_IVS1-IVS3. The two other probes were from intergenic DA regions:
TPM1_tel3200 and CTCFL_cen34302. One equivalent accessible (EA) probe from an
intergenic region, 3.3_1p36, was selected as a control.
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DA regions were selected, in part, based on having no or low expression (0.0 to 5.0
TPM) across all tissues. This was done to control for differences in expression across one or
more tissues complicating interpretation of conservation of DA between tissues. Expression
data in transcripts per million (TPM) were reported for each gene in which a confirmed DA or
EA scFISH probe localized using data from the GTEx78 and Human Protein Atlas (HPA)79
databases (Figure 3.16, Figure 3.17). The list of genes for which expression data was collected
was assembled from DA and EA regions identified from the domain studies, previously
published regions identified as DA or EA7, and studies from our laboratory identifying DA
regions from examination of historical gene mapping studies71. This maximized the number of
regions selected from (DA n= 41, EA n= 26) when determining the probes to be used for
comparison between tissues. Data presented include EA regions within genes, however, time
did not allow this study to include a probe hybridizing to an EA region within a gene.
From the data collected, the genes investigated showed variation in the mean level of
expression from 0 TPM to values >100 TPM with comparable variation in expression observed
across genes in both DA regions (Figure 3.16) and EA regions (Figure 3.17). There were also
variable differences in expression when comparing between the three tissues of interest,
lymphocytes, bone marrow, and fibroblasts, at the same locus both within DA and EA loci.
Comparable variations in expression between DA and EA loci within genes, as well as between
tissues at the same locus along with the observation of intergenic DA and EA regions does not
support a role of DA in regulating tissue-specific expression. Of note is that data from the
HPA were already presented as mean values and therefore standard deviation was unable to be
calculated nor represented for bone marrow data as individual values for each tissue were not
available.
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Figure 3.16: Mean gene expression in transcripts per million (TPM) reported for each gene in which a confirmed DA scFISH
probe localized. Data reported includes both previously published7 and recently identified DA regions within genes. B lymphocyte and
fibroblast data were obtained from GTEx78. Bone marrow data were obtained from the Human Protein Atlas79. Error bars representing
standard deviations were calculated for data collected from the GTEx database78 but not for HPA data (see text).
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Figure 3.17: Mean gene expression in transcripts per million (TPM) reported for each gene in which a confirmed EA scFISH
probe localized. Data collected was from all previously reported EA regions within genes7. B lymphocyte and fibroblast data were
obtained from GTEx78. Bone marrow data were obtained from Human Protein Atlas79. Error bars representing standard deviations were
calculated for data collected from the GTEx database78 but not for HPA data (see text).
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3.3.2 Conservation of DA Loci in T-Lymphocytes, Cells from Bone Marrow, and
Fibroblasts
All DA loci were conserved across all three tissues. The characteristic probe fluorescence
difference between homologues was observed in all loci investigated within genes
XDH_IVS30-IVS27, PCK1_cen180-IVS6 (Figure 3.18), and DUOX1_IVS1-IVS3 and in
intergenic regions, TPM1_tel3200 (Figure 3.19) and CTCFL_cen34302. Examples of the
fluorescence difference between homologues both in a gene and in an intergenic region across
tissues are given in Figure 3.18 and 3.19. A significant number of cells were scored as DA at
all DA loci investigated in all tissues using a two-tailed binomial test with normal
approximation (Appendix VII). An intergenic EA probe, 3.3_1p36, was also included to
investigate the conservation of a locus known not to show DA in T-lymphocytes between the
same tissues. The presence of EA was also determined using a two-tailed binomial test with
normal approximation (Appendix VII). Equivalent accessibility between homologues was
conserved between lymphocytes, bone marrow and fibroblasts at the EA locus (Figure 3.20)
suggesting that both EA and DA loci are maintained between tissues types. The conservation
of DA in bone marrow was not surprising as both peripheral lymphocytes and bone marrow
are derived from stem cells located in bone marrow.
A non-parametric Kruskal-Wallis test determined that the presence of DA was
statistically indistinguishable (p>0.99 at each locus) between T-lymphocytes, bone marrow,
and fibroblasts (Figure 3.21). The same test found the presence of EA at 3.3_1p36 to be
indistinguishable between tissues (p>0.99) as well. Therefore, we assume that the accessibility
at these loci are indistinguishable between these 3 tissues and define these as a conserved
property at these loci in mitotic chromosomes.
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PCK1_cen180-IVS6
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Bone Marrow
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Figure 3.18: The PCK1_cen180-IVS6 region shows the conservation of DA within a gene
in metaphase T-lymphocyte, bone marrow, and fibroblast cells. Human metaphase
homologous chromosomes hybridized with PCK1_cen180-IVS6 (chr20q13.3: 56,135,95756,139,048), a single-copy FISH probe, to T lymphocyte (left), bone marrow (center) and
fibroblast (right) cells. Both homologues hybridized by the scFISH probe are indicated with
arrows on the full metaphase and below in the magnified images of each homologue. The Tlymphocyte cell has 1 dim hybridization (left homologue) compared to 2 bright (right
homologue). The bone marrow cell has no hybridization (left homologue) compared to 2 bright
(right homologue). The fibroblast cell has a dim (left homologue) compared to 1 bright and 1
medium (right homologue). The differential hybridization intensity observed across all tissues
is characteristic of DA.
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TPM1_tel3200
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Figure 3.19: The TPM1_tel3200 region shows conservation of DA in an intergenic region
in metaphase T-lymphocyte, bone marrow, and fibroblast cells. Human metaphase
homologous chromosomes hybridized with TPM1_tel3200 (chr15q22.2: 63,367,31463,369,607), a single-copy FISH probe, to T lymphocyte (left), bone marrow (center) and
fibroblast (right) cells. Both homologues hybridized by the scFISH probe are indicated with
arrows on the full metaphase and below in the magnified images of each homologue. The Tlymphocyte cell has 1 bright and 1 medium hybridization (left homologue) compared to 1 dim
(right homologue). The bone marrow cell has 2 bright hybridizations (left homologue)
compared to 0 (right homologue). The fibroblast cell has a medium (left homologue) compared
to 2 bright (right homologue). The differential hybridization intensity observed across all
tissues is characteristic of DA.
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Figure 3.20: The 3.3_1p36 region shows conservation of EA in metaphase T-lymphocyte,
bone marrow, and fibroblast cells. Human metaphase homologous chromosomes hybridized
with 3.3_1p36 (chr1p36:1,171,789-1,175,143), a single-copy FISH probe, to T lymphocyte
(left), bone marrow (center) and fibroblast (right) cells. Both homologues hybridized by the
scFISH probe are indicated with arrows on the full metaphase and below in the magnified
images of each homologue. In the T-lymphocyte cell both homologues have 1 bright and 1 dim
hybridization. The bone marrow cell has 2 medium hybridizations (left homologue) compared
to 1 medium (right homologue). The fibroblast cell has 1 bright hybridization (left homologue)
compared to 1 bright and 1 medium (right homologue). The equivalent probe hybridization
intensity observed across all tissues is characteristic of EA.
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Figure 3.21: Proportion of cells scored as DA (black) and EA (grey) within lymphocytes,
bone marrow cells, and fibroblasts are not significant. Regions include 3 DA regions within
genes, 2 intergenic DA regions, and 1 EA region. Across the tissues examined for each DA or
EA region, the accessibility between metaphase homologues remained the same, DA loci
remained DA and EA loci remained EA, with a significant difference calculated between cells
scored as DA and EA. No significant difference was found between the proportion of cells
identified as DA between the 3 tissues investigated. Sample size differs between each tissue
and each probe (Appendix VII). Significant differences were calculated using a Kruskal Wallis
test (!=0.05) when comparing between tissues and proportion of cells scored as DA and EA.
(ns= not significant)
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In all cases where two different samples were analyzed for each tissue type a two
proportion Z-test was used to test the difference between individuals (Appendix VII). There
was no significant difference found between individuals (n=8) at all DA loci and the single EA
locus across all tissues, with the exception of the 2 bone marrow samples hybridized with
CTCFL_cen34302 (p = 0.004). Both samples showed DA, it was the proportion of DA cells
scored in each sample that differed. This difference, as previously mentioned with
SCAMP2_IVS7-IVS4 in lymphocytes, could be stochastic or individual related.
DA conservation at the same loci in T-lymphocytes and bone marrow suggests DA is
present and maintained at the same locus in other peripheral blood cells, T- and B-lymphocytes,
as well as progenitor lymphocyte cells at various stages of differentiation. Repeating scFISH
experiments in fibroblasts yielded similar results providing evidence of DA in tissues derived
from both ectoderm and mesoderm germ layers. These observations of conservation of both
DA and EA demonstrated that accessibility patterns between homologues during metaphase
are not a feature unique to lymphocytes. Of note is that 4 of the DA loci conserved in the 3
tissues were found within 3 of the domains described in this study. XDH_IVS30-IVS27 within
the XDH domain, TPM1_tel320 part of the TPM1 domain and PCK1_cen180-IVS6 and
CTCFL_cen34302 both within the HMGB1P1 domain. This is evidence that the DA domains
described and characterized within peripheral lymphocytes may also be maintained between
bone marrow and fibroblasts.
It should be noted that not all loci could be investigated with 2 patient samples for each
tissue type. In bone marrow data from only 1 individual hybridized with TPM1_tel3200 was
reported; in fibroblasts hybridization data from DUOX1_IVS1-IVS3, TPM1_tel3200, and
XDH_IVS30-IVS27 was only reported from a single individual. This was due to the quality of
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chromosomes from individual sample preparations restricting the number of slides that met the
quality needed for analysis. Use of a sample from a second individual for these probes would
be ideal, however each probe had already been mapped and validated in 2 individuals in
lymphocytes, and therefore a second individual in each tissue was not a requirement.
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Chapter 4: Discussion
4.1 Identification and Validation of New DA Loci
Eighteen previously unknown DA loci were identified in this study. These loci and one
previously published EA locus were validated to confirm their respective metaphase
homologue accessibility. Trends observed during the initial characterization of DA were
compared with those of the newly identified DA regions. These loci were not identified
randomly, which based on previous studies from our laboratory would have resulted in a higher
prevalence of EA loci. The experimental design of defining domains based on anchor scFISH
loci known to exhibit DA resulted in enrichment of neighbouring DA sequences. The DA
regions identified for this study were located on chromosomes 2, 3, 12, 15, and 20. The DA
loci

on

chromosomes

2

(XDH_tel9264,

XDH_tel2387,

XDH_IVS30-IVS27)

and

3

(ZNF385D_tel640535, ZNF385D_tel678016) were the first differentially accessible loci to be
identified on those chromosomes. The DA loci reported in this study further expand the
presence of DA across the genome from previously verified regions. There now are confirmed
DA regions, new and previously reported7, identified on 16 of the 24 possible human
chromosomes.
A significantly higher proportion of cells were identified as DA at all new DA loci
compared to the EA locus that had a significantly higher proportion of EA cells. This is
consistent with previously described characterization of differential accessibility between
metaphase homologous chromosomes7,8. The proportions of cells showing DA in different
individuals analyzed at the same locus were not significantly different in T-lymphocytes with
the exception of SCAMP2_IVS7-IVS4. At the SCAMP2_IVS7-IVS4 locus, DA was evident in
both samples, it was only the proportion of cells exhibiting DA that appeared to differ. This
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difference could be a stochastic occurrence. This was the only occurrence in the different
combinations of 2 individuals investigated per probe locus from a total of 23 individuals
included in the T-lymphocyte studies. The difference could also be due to differences in the
quality of the metaphase chromosomes between the samples, based on their respective
chromosome morphologies and lengths (ie. resolution). Regardless of the observed variability
in the proportion of DA cells, according to our definition, SCAMP2_IVS7-IVS4 was scored
the same between samples.
Observed differences in probe fluorescence intensity between metaphase homologues
were confirmed by quantification of integrated probe signal intensities using GVF analysis.
Quantification of the signals of 5 DA probe regions confirmed that the ratio of fluorescence
intensities between homologues was different than that of the EA region. The median
difference of integrated intensity ratios between DA regions (0.82) was significantly different
compared to the median of the EA region (0.23) analyzed. This was a trend that was consistent
with previous comparisons of reported DA and EA regions7. The range of both DA and EA
datasets were 0.002 – 1.0, indicating DA and EA cells were represented in each dataset. This
is due to the heterogeneous presentation of DA within a sample. The difference between
classification as either DA or EA, the higher proportion of one accessibility pattern over the
other, can be observed in the distribution of the values within the interquartile ranges. All EA
data for this analysis were collected from a single EA locus. Expanding the number of EA loci
included in this analysis would not be expected to change the significant difference between
the fluorescence intensity ratios between DA and EA regions. However, the overall variation
of the EA dataset would be expected to decrease with an increased number of EA loci than that
from a single locus. This is due to more variation in the possible differences in probe intensities
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at DA loci (e.g. dim/bright, bright/medium) compared to EA loci where a significantly larger
number of cells have equivalent fluorescent intensities. The median values and the significant
difference between them, support the classifications made qualitatively of the new DA loci.
The final point of comparison between the new DA regions identified in this study and
the trends of previously characterized EA and DA regions was looking at epigenetic marks of
open chromatin present during interphase. This analysis served to provide further support for
the characterization of new regions as DA as well as continued investigation into possible
connections between chromatin accessibility during metaphase and structural features present
during interphase. Previously identified DA loci were reported to have significantly lower
enrichment of marks of open chromatin (DNase 1 HS, FAIRE, and histone modifications
H3K4me, H3K9ac, H3K27ac, and H3K4me2) compared to loci with equivalent accessibility7.
The same general trend was observed for the DA loci identified in this study, with significantly
lower mean integrated intensity values of DNase I, H3K9ac, H3K27ac, and H3K4me2 at DA
loci compared to previously published EA regions. FAIRE and H3K4me integrated intensity
values of DA regions had a lower mean value than EA regions however this difference was not
statistically significant. The consistency of the trend between open chromatin mark levels of
previously identified DA regions and those identified in this study further supports the
classification of each previously unidentified region as differentially accessible.
The loci, SCAMP2_IVS1, was removed from the DA data set before analysis, as it
differed substantially in the enrichment of open chromatin marks, DNase I HS, FAIRE,
H3K9ac, H3K27ac, and H3K4me2, compared to other DA loci. Enrichment of these marks
were indicative of open chromatin whereas other DA loci, identified in this study and
previously published7, did not show the same level of enrichment. It is not known at this time
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why this particular DA locus is so different in open chromatin mark enrichment compared to
others characterized. However, previous work in our laboratory has shown that inhibiting
histone dephosphorylation, deacetylation, and demethylation in interphase did not affect the
presence of DA during metaphase, and that the difference between homologues is due to a
difference in chromatin supercoiling facilitated by topoisomerase II!8. These data show that
individual histone modifications did not have an effect on the formation of DA loci during
metaphase, and a difference in enrichment of a given histone modification did not dictate the
formation of a given DA locus. An important consideration is that the data assembled for all
open chromatin marks were from an EBV immortalized lymphoblastoid B-cell line, while DA
data were reported from non-immortalized PHA-activated T lymphocytes. We assume that
these are the same, given that they are from the same tissue (peripheral blood), however there
could be differences in open chromatin mark enrichment profiles between T-cells and B-cell
derived lymphoblasts. This may be the case at SCAMP2_IVS1. In terms of an identifying factor
of DA and EA loci, a DA region with clear enrichment of open chromatin marks but with
scoring data that clearly indicates a DA locus may suggest a more variable enrichment of open
chromatin marks across DA and EA regions than currently represented and therefore may not
alone be specific enough to DA regions in metaphase to provide a distinct profile to identify
new DA loci. Another unrelated sample should be investigated to confirm the characterization
of SCAMP2_IVS1 as DA.

4.2 Definition of Six DA Domains
Using the new DA loci identified and validated as described in the results, 6 DA domains were
defined in this study. DA domains were defined in this study as sections of the genome over
which multiple DA loci have been identified in neighbouring single-copy regions with the
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boundary of each domain demarcated by the genome coordinates of the two DA probes that
are the greatest distance apart. An important caveat of the definition of the boundaries of these
domains, is that the ends of each domain were not defined by identification of flanking EA
regions but rather by the outer DA loci for each domain. This was partly due to the method of
scFISH being a time intensive process, taking multiple weeks to go from probe design and
development to analysis of scFISH images. This was also a constraint in incrementally
increasing the borders of each domain until EA regions were identified. The domains identified
in this study, however, provide evidence of DA regions that extend beyond the borders of
individual scFISH probes and may occupy much larger genomic lengths than the evidence
identifying DA regions with short scFISH probes implied.
The domains extend over genes and intergenic regions with DA loci confirmed in
intronic, exonic and intergenic regions. These along with previously identified DA loci,
demonstrate DA in gene coding and non-coding areas of the genome. Domains range in size
from ~16.0 to ~129.6 kb, defined by 2 to 4 DA scFISH probes. The shortest of these domains,
FGF6, TPM1, and XDH covering ~16.0, ~16.0 and ~25.5 kb, respectively, are evidence of
multiple neighbouring DA loci in close proximity. The TPM1 domain contains 3 DA regions
all located within 16kb, with less than 2kb separating TPM1_IVS5-IVS8 and TPM1_IVS8.
This along with the close proximity of the 2 DA regions of the FGF6 domain and the 3 DA
regions of the XDH domain suggests that differential accessibility is a structural characteristic
of metaphase chromatin that extends beyond the boundaries of the scFISH probes used to
identify it.
Presently scFISH probes are the only way to detect DA, and they detect genomic
lengths from 1.5 to 5 kb in length. Domains provide evidence that the differential accessibility
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detected by these single-copy probes is a larger feature than the boundaries of individual
scFISH probes. Initial characterization of DA listed some pairs of DA loci in close proximity,
the initial design of these scFISH probes being used to investigate areas of pathologically
relevant loci to identify cytogenetic abnormalities7,9,10. These areas were not addressed further
during the initial characterization of DA loci. Through the domains identified in the present
study, this suggests that the DA probes in close proximity listed in the previous study may also
be part of a larger DA domain, rather than individual short lengths of differences in
accessibility. In the other three domains, HMGB1P5, COX5A, and HMGB1P1, there are larger
gaps between the DA regions identified using scFISH. These areas may not be characterized
as continuously differentially accessible across the defined domain. However their proximity,
as either a large DA domain or multiple smaller DA domains close together, suggest that DA
occurs more often within neighbouring single-copy regions than the placement of previously
reported DA regions described.
As mentioned above none of the DA loci defining each domain are directly adjacent to
each other and there is varying lengths of genome sequence separating them. The shortest
distance between DA loci is ~ 1.4kb, and the largest ~87.3 kb. Due to constraints in designing
single-copy FISH probes, regions directly in tandem were rarely able to be produced. This was
mostly due to repetitive elements present within these regions. ScFISH probes are designed to
hybridize to unique sequence within the genome, only occurring once. Therefore, sequences
containing repetitive elements with divergent sequences < 20% are excluded to avoid
nonspecific cross-hybridization across the genome. The possibility of cross-hybridization has
also been reduced by including a 300 bp cushion from surrounding repetitive elements adjacent
to each sc interval65. This is known to reduce the probability of probe segments being extended
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during amplification to include those repetitive elements65. There was also a restriction on
probe size, as scFISH probes cover short genomic segments (1.5 to 5 kb). Minimum probe
length was kept close to ~ 1.5kb in length in order to readily visualize the hybridization with
epifluorescence microscopy10.
After establishing the presence of DA domains in mitotic metaphase, the potential
correspondence between DA domains and higher-order chromatin structures present during
interphase was examined. Larger chromatin organizations that are involved in the regulation
of cell function, including topologically associated domains (TADs), were considered as DA
loci were determined to occupy larger areas than that of scFISH probes. Besides modifications
at the nucleotide and histone levels, the increasing hierarchy of interphase chromatin
organization including chromatin loops, TADs, and A/B compartments are also important for
coordinated expression of genes in cells30. TADs in particular with their compartmentalization
of expression programming, allow contact within the domain but insulate gene targets from
influence beyond TAD boundaries22,30. These important structures are lost during mitosis
(when cells are largely transcriptionally inactive), to allow condensation of chromatin41,42. The
mechanisms responsible for re-establishing these structures in daughter cells are still unknown.
The location of DA domains and interphase chromatin organizations were examined to
investigate whether the extent of DA domains and TAD boundaries were related to one
another.
Of the 6 domains, 5 were found to occupy areas each within their own respective TAD.
The HMGB1P5 domain was found in the interval between two TADs. None of the DA loci
were found to cross any of the given TAD boundaries in the lymphoblastoid cell line analyzed.
The XDH, FGF6, COX5A, and HMGB1P1 DA domains had a high degree of interaction in
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interphase with other segments within the same TAD, suggesting sub-TAD structures with
high frequency intra-TAD interactions occuring within a single TAD. The TPM1 domain
interacted with some areas within the TAD. However, these interactions were not as strong
compared to the other domains found within TADs. The HMGB1P5 domain, found between
TADs, lacked high frequency interactions observed over the domains in metaphase. These
findings are all qualitative associations consistent with a connection between the location of
TADs in interphase and DA loci in metaphase.
A more in-depth investigation should be completed to begin to answer if there is a
connection between these interphase and metaphase structures. Determination of a change in
the accessibility between homologues in the adjacent TAD would provide stronger evidence
of a possible connection to DA domains. New scFISH probes would be designed for the
COX5A and TPM1 domains as both are close to the edge of their respective TAD and into the
closest adjacent TAD. If results using these new probes suggest alternating TADs during
interphase, consistent with alternating accessibility between metaphase homologues, that
would be more compelling evidence of DA as a potential structural memory of TAD structures
through metaphase. No change between adjacent TADs, would be inconsistent with the
connection just described. In addition, the HMGB1P1 domain, found in the center of a TAD,
could be expanded beyond the boundaries of the sub-TAD directly above the domain into more
distant areas of intra-TAD interactions. Changes in metaphase accessibility within a single
TAD, could suggest DA as a mitotic memory for the more minute sub-TADs within each TAD
rather than the larger TAD itself. Observations in this study are based on 6 domains. Therefore,
addressing if there is a true connection between DA domains and TADs would require a more
expansive analysis of metaphase chromatin accessibility genome-wide and Hi-C chromatin

97
conformation data describing TAD structures. A full genome investigation into the
accessibility between metaphase homologues would even further increase the ability to
compare the occurrence of TADs and that of DA.
Potential relationships between the DA domains, TADs, and higher-order chromatin
structures were investigated further by comparing the distributions of CTCF binding site
clusters within DA domains and the location beyond the boundaries of those DA domains.
CTCF binding to chromatin facilitates the formation of TADs and other chromosomal
loops22,30,89. TAD boundaries have been characterized by enrichment of CTCF acting to
insulate the interior of the TAD from external genomic regulators, separating independently
regulated transcriptional regions from one another22. The removal of CTCF binding sites
during interphase leads to the loss of TAD structures89. However, the relationship between
CTCF binding and loop formation in mitotic chromosomes is controversial due to
contradictory evidence of CTCF binding during mitosis90. A recent study, however, presents
evidence that CTCF-site specific binding is lost during mitosis90. The ability to re-establish
CTCF binding at specific sites is crucial to restore correct TAD and chromatin looping after
cell division. The results do not support a significant difference between the distributions of
predicted CTCF binding sites within a domain, in the adjacent TAD and within the same TAD
beyond the borders of the domain. Notably, DA probes defining the COX5A and TPM1
domains located near the edge of their respective TADs, in addition to the HMGB1P5 domain
located close to an adjacent TAD, are all near boundaries expected to be enriched with CTCF.
Despite the lack of correspondence between predicted CTCF binding site distributions
and TAD boundaries, future investigations into the connection between CTCF binding sites
and DA domains still deserve consideration. The genomic segments selected for comparison
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were selected based off their relative location to DA domains and interphase TAD structures.
They had unknown homologous chromosome metaphase accessibility, so comparisons could
have been made between different differentially accessible domains. Also, data were only
analyzed within the domain and to 1 Mb on either side of the domain. Repeating this analysis
by expansion into known EA loci and previously identified DA loci, or even expanding
genome wide, would allow for a larger sample size and comparison between binding site
affinities in DA and EA loci. There is also the consideration that CTCF binding sites are not
only found at TAD boundaries but rather throughout the genome promoting localized
chromatin looping and accessibility for transcription factors. Another limitation of this study
was that the DA domains defined were not all located near the boundaries of the TADs in
which they were observed. When more extensive data of the accessibility between metaphase
homologues is generated, a more robust comparison can be conducted.
An alternative domain structure that DA domains could be compared with is a newly
reported chromatin domain described by Nozaki et al. 20172. These are dynamic domains of
~160nm formed by compaction of nucleosomes whose organization is influenced by a number
of factors during interphase including cohesion and nucleosome-nucleosome interactions2.
They were identified using live cell imaging of nucleosomes by tracking a modified H2B
histone2. The main point of interest is nucleosome domains similar in structure to those
observed in interphase were also observed in mitotic cells, both in fixed and live cells2. This
group proposes that these domains remain throughout the cell cycle acting as “building blocks”
of chromosomes2. Early establishment of these nucleosome domains was proposed, as the
domains were not clear structures in mouse embryonic stem cells, but upon differentiation to
embryonic bodies (aggregates of pluripotent cells resembling early embryos) the domains
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became more defined2. Early establishment of DA would also be anticipated, if DA is a stable
mark, with the evidence of DA in both mesoderm and ectoderm derived cells. A similarity was
drawn between these domains and TADs in the involvement of cohesion in their formation,
though the preservation of these domains into metaphase separates the two. This group
speculates that the role of domain formation in mitosis is taken up by condensin as cohesion
largely dissociates during mitosis to allow chromosome condensation2,91. Mutations in
cohesion have been shown previously to not affect the presence of DA in metaphase with DA
resulting from a difference in supercoiling facilitated by topoisomerase II!8. The other major
protein involved in chromatin condensation during mitosis, condensin, was unable to be
studied due to mutations in this protein resulting in a large disruption in chromatin structure
and mislocalization of topoisomerase II!8. The observed conservation of these domains into
mitosis through the loss of cohesion, and the possible role of condensin, a key protein involved
in condensing chromatin during mitosis, offers a potential chromatin structure to investigate
further and compare with DA domains.

4.3 Conservation of DA Loci Across Tissue Types
The presence of DA loci had previously only been reported in peripheral T-lymphocyte cells.
This study found DA was conserved at the same loci across 3 different tissues types:
lymphocytes, mitotic cells from bone marrow, and dermal fibroblasts. Confirmation that DA
is not a feature specific to lymphocytes is supported as it occurs in cells at varying stages of
differentiation as well as in cells originating from different germ layers during development.
The expression of each gene in which a DA or EA loci had been identified was
examined using data from two different public databases. Data from both databases, GTEx and
Human Protein Atlas, was included to compare expression between tissues at each locus. These
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data were used to select DA loci with no to low levels of expression across all three tissue types
to avoid the complication of potential result interpretation by differences in expression between
tissues. Direct expression levels of the tissues examined in this study were not measured.
Three of these DA loci which occurred within genes as well as two DA loci found in
intergenic regions were found to be present in all tissues. The conservation of DA loci between
peripheral lymphocytes and bone marrow suggests the presence of DA at multiple levels of
hematopoiesis. The mitotic cells present in bone marrow would have not only included B
lymphocytes but also various lymphocyte progenitor cells at different stages of differentiation
as well as those of cells of myeloid origin. Of note is that bone marrow as a sample type is a
heterogenous mixture of cells dividing at various stages of differentiation and this study did
not seek to isolate or identify the identities of the mitotic cell subtypes comprising the mixture
of each sample. If the stem cell composition was biased towards a predominantly prelymphocytic progenitor population, the observed conservation of DA loci would have been
anticipated.
In addition to cells from the both PHA stimulated T-lymphocytes and bone marrow
cells, there was also conservation of DA loci in dermal fibroblasts. This provides evidence of
DA in cells derived from both the mesoderm (lymphocytes) and ectoderm (fibroblasts). All of
the selected DA loci that were shown to be conserved either had 0 to low transcription in all 3
tissues or were in intergenic regions. Also conserved was the EA region located within a noncoding region. As stated earlier, all the regions investigated in this study were selected because
they showed either no or low gene expression levels in order to avoid complicating data
interpretation with presence of differential expression between tissues. Further analysis that
includes an additional EA control within a gene would be ideal in order to determine, if similar
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to DA, EA loci are maintained in both genes and intergenic regions. Expanding the regions
investigated to also include DA loci in regions with expression greater than 5 TPM would
strengthen characterization of DA across different tissues. Conservation has not been examined
in genes with expression >5 TPM, though the presence of DA in intergenic regions does not
support a role for DA in tissue-specific programming Regardless, these data suggest that DA
is a feature present between homologous chromosomes during metaphase across a variety of
cell types and is not concentrated only in lymphocytic tissues. The conservation of DA between
tissue types opens more avenues of investigation into the origin and relevance of DA.
Of the 5 DA loci compared between these tissues, 4 were involved in defining 3
different DA domains. This included one locus each, from the XDH domain and the TPM1
domain, and 2 loci from the HMGB1P1 domain. The presence of these loci across different
tissues types suggests that not only are loci with DA maintained but also larger DA domains
defined in this study are also conserved between these tissue types. The location of TAD
boundaries is well-maintained between tissue types whereas the location of sub-TAD
interactions are cell-type specific21,22,30,92. The establishment of TADS has been identified
early in human embryogenesis, with well-defined TADs occurring by the 8-cell stage92. If
metaphase chromatin accessibility between homologues is stable related to TAD location
through multiple cell divisions and differentiation, then DA could be maintained between
different tissue types originating from different germ layers of the early embryo. Although a
number of high frequency intra-TAD interactions, indicating sub-TAD structures, are observed
over the location of 4 of 5 DA domains during interphase, the evidence of DA in lymphocytes
and fibroblasts suggest a possible relationship between the larger TAD structures rather than
the internal cell-type specific sub-TADs. The identification of conserved DA loci has been
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shown across genes with no or low expression and intergenic regions. DA conservation
between tissues in genes showing differential expression between tissues was not studied.
An area of interest is the examination of DA loci across different stages of
differentiation of lymphocytes, as well as between activated and inactivated mature
lymphocytes. DA loci conserved in lymphocytes and bone marrow suggests that DA is present
in progenitor B lymphocytes as well as the mature cell type, identified in both inactivated B
and activated T lymphocytes. Changes in chromatin accessibility are not limited to stages of
hematopoietic stem cell differentiation, large changes have also been observed and
characterized in both B cells and T cells following activation with an antigen93,94. This presents
a specification pathway with multiple stages of chromatin rearrangements over which the
conservation of DA can be investigated. The presence of DA in tissues derived from two
different germ layers also brings up the question of when during development is DA
established. If DA is a stable mark through development then observation of DA in both
mesoderm and ectoderm derived cells would indicate early establishment in embryogenesis.
Establishing the stages of development and differentiation that DA is present at the same loci
would indicate when DA is established and where it is conserved. Conserved across the
selection of tissues in this study, as well as potential broader conservation across other cell
types at the same loci would support a deliberate establishment of specific areas of equivalent
and differential accessibilities between metaphase homologues during cell division.

4.4 Conclusion
Differential accessibility (DA) between metaphase homologous chromosomes is a unique
feature of metaphase chromatin. Initially observed in peripheral lymphocytes, DA is a stable
locus-specific and heritable feature that has been observed in ~10% of >300 single-copy loci
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investigated. The results of this study were able to show that DA is not confined to the
boundaries of short scFISH probes but rather extend to form larger, contiguous domains with
the same differential accessibility epigenotype between homologues. Large regions of DA
were identified and defined, however clear boundaries that separate these domains from
adjacent areas of equivalent accessibility were not determined. The location of 5 of these
domains were found within their own respective TADs. Previously published work from our
laboratory has demonstrated that 90% of single-copy probes derived from regions containing
clinically relevant cytogenetic genes/regions exhibit EA7. It is therefore highly likely that
further expansion from current DA domains will reveal these boundaries for the domains
described here.
This study also established that these DA loci are conserved between blood, bone
marrow, and fibroblast tissues. This suggests that differentially accessible loci are found at
different stages of hematopoiesis and lymphocyte differentiation as well as in tissues derived
from multiple germ layers present during early development. The identification of DA regions
that are preserved between different cell types, and across the genome within genes and
intergenic regions does not support a tissue-specific role of DA. The findings are consistent
with the hypothesis that DA might contain or harbour structural marks of chromatin memory.
The expansion of DA loci into domains and their conservation between tissue types further
characterizes this metaphase structure.
From the data reported, multiple avenues could be pursued to further investigate the
role of equivalent and differential accessibility between metaphase homologues. DA and EA
could be the result of mitotic bookmarking, with specific loci maintained through mitosis in
multiple tissue types to allow rapid restoration of necessary transcription programming
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immediately following mitosis. Or it could serve in interphase as mitotic memory of functional
chromatin domains, such as TADs, to preserve their exact location so following their loss in
metaphase these structures can be faithfully restored in daughter cells. Disruption of any of
these processes could be the cause of abnormal functions at multiple levels. Examination of
aberrant phenotypes have already begun in which a dysregulated gene is not the result of a
mutation within the gene itself but rather a disruption of distant regulatory elements or
chromatin organization facilitating abnormal contact of regulatory elements with unintended
genes52. Further understanding of the mechanisms and structures that allow rapid and precise
re-establishment of chromatin organizations and modifications, necessary for correct
regulation and function of cells, is essential.
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APPENDICES
Appendix I: Gene Names
COX5A – Cytochrome C Oxidase Subunit 5A
CTCFL – CCCTC-Binding Factor Like
DUOX1 – Dual Oxidase 1
FGF6 – Fibroblast Growth Factor 6
HMGB1P1 – High Mobility Group Box 1 Pseudogene 1
HMGB1P5 – High Mobility Group Box 1 Pseudogene 5
PCK1 – Phosphoenolpyruvate Carboxykinase 1
RPM38 – RNA Binding Motif Protein 38
SCAMP2 – Secretory Carrier Membrane Protein 2
TPM1 – Tropomyosin 1
XDH – Xanthine Dehydrogenase
ZNF385D – Zinc Finger Protein 385D
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Appendix III: Python script reporting mean expression values of RefSeq genes in
lymphocytes, bone marrow, and fibroblast cells from the Human Protein Atlas
(HPA) and Genotype-Tissue Expression (GTEx) databases
import csv
import sys
import statistics
# list of keywords for tissues of interest, general and specific to search through files, taken
from list of tissues (GTEx, Protein Atlas)
tissues_of_interest = ['Blood', 'blood','Whole Blood', 'whole blood', 'Cells - EBV-transformed
lymphocytes',
'Skin', 'skin', 'Hematopoietic Stem Cells', 'hematopoietic stem cells', 'Bone marrow', 'bone
marrow',
'Placenta', 'placenta', 'Transformed fibroblasts', 'transformed fibroblasts','Cells - Transformed
fibroblasts',
'Skin - Not Sun Exposed (Suprapubic)', 'Skin - Sun Exposed (Lower leg)'
]
lymphocyte = ['Cells - EBV-transformed lymphocytes']
wholeblood = ['Blood', 'blood','Whole Blood', 'whole blood']
skin = [ 'Skin', 'skin','Skin - Not Sun Exposed (Suprapubic)', 'Skin - Sun Exposed (Lower
leg)']
fibroblast = ['Transformed fibroblasts', 'transformed fibroblasts','Cells - Transformed
fibroblasts']
hematopoietic = [ 'Hematopoietic Stem Cells', 'hematopietic stem cells']
bone_marrow = ['Bone marrow', 'bone marrow']
prenatal = ['Placenta', 'placenta']
"""
Make dictionary to allow conversion of sample name to their tissue of origin
"""
handle1 = open('E-MTAB-5214.sdrf.tsv') #open information of tissue type corresponding
to sample name
line = handle1.readline() #skip header
sample = []
tissue_type = []
for line in handle1:
category = line.strip('\n').split('\t')
sample.append(category[0]) #keys = sample name
tissue_type.append(category[5]) #values = specific tissue type information
specfic_tissuetypes = dict(zip(sample, tissue_type)) #make dictionary to interpret samples as
their tissue types

V
handle1.close()
def output_TPM_GTEx(input, output):
"""
Input file formatted by GTEx; extract and report data points only of tissues and genes of
interest.
Two file types anticipated:
1. full data set with all samples where need to identify the tissue of origin of each sample
reported and
calculate the mean expression in transcripts per million (TPM) for genes of interest
2. summarized data with tissue types given where need to isolate and report tissues and
genes of interest
"""
handle = open(input) #GTEx date set
_ = handle.readline()
_ = handle.readline()
samples = handle.readline().strip('\n').split('\t') #isolate each sample name in 3rd line
#lists of each column position of target tissue type samples
lymph = []
blood = []
fibro = []
peau = [] #list for skin
hemato = []
marrow = []
pren = []
for sample in samples: #add positions of target tissues into specific lists
if sample in tissues_of_interest: #if sample given as tissue types make lists for each
category of tissue/cell
if sample in wholeblood:
blood.append(samples.index(sample))
if sample in lymphocyte:
lymph.append(samples.index(sample))
if sample in fibroblast:
fibro.append(samples.index(sample))
if sample in skin:
peau.append(samples.index(sample))
if sample in hematopoietic:
hemtao.append(samples.index(sample))
if sample in bone_marrow:
marrow.append(samples.index(sample))
if sample in prenatal:
pren.append(samples.index(sample))

VI
else: #if not, convert sample name to tissue type and collect positions of targeted tissues
tissuetype = specfic_tissuetypes.get(sample, None)
if tissuetype in tissues_of_interest:
if specfic_tissuetypes is None:
continue
if tissuetype in wholeblood:
blood.append(samples.index(sample))
if tissuetype in lymphocyte:
lymph.append(samples.index(sample))
if tissuetype in fibroblast:
fibro.append(samples.index(sample))
if tissuetype in skin:
peau.append(samples.index(sample))
if tissuetype in hematopoietic:
hemtao.append(samples.index(sample))
if tissuetype in bone_marrow:
marrow.append(samples.index(sample))
if tissuetype in prenatal:
pren.append(samples.index(sample))
#list of tissuetype lists to iterate over
tissue_lists = [lymph, blood, fibro, peau, hemato, marrow, pren]
#dictionary of the position lists and corresponding tissue to allow identification of tissue
types in new file
tissue_types = {str(lymph):'Lymphocytes', str(blood):'Whole Blood',
str(fibro):'Fibroblasts',
str(peau):'Skin', str(hemato):'Hematopoietic Stem Cells', str(marrow):'Bone Marrow',
str(pren):'Prenatal'
}
outfile = open (output, 'w') #open new file with results
reader = csv.reader(handle, delimiter='\t', quotechar='"')
writer = csv.writer(outfile, delimiter='\t', quotechar='"')
results = []
for row in reader:
gene = row[1] #gene name in 2nd column
if gene in sys.argv[1:]: #iterate over the gene names within the file, match with those
entered in terminal
total = 0
for item in tissue_lists:
if len(item) == 1: #if only one data point per tissue assume summarized data,
report as given
for position in item:

VII
total = float(row[int(position)])
tissue = tissue_types.get(str(item), None) #corresponding tissue type to list
item
result = gene, tissue, total
results.append(result)
if len(item) != 0: #if there is a sample that matches a tissue of interest
listTPM = []
for position in item:
TPM = float(row[int(position)])
tissue = tissue_types.get(str(item), None)
listTPM.append(TPM)
result = gene, tissue, total, statistics.mean(listTPM), statistics.stdev(listTPM)
writer.writerow(result) #write the result to a new file with gene name and tissue
type
for result in sorted(results):
writer.writerow(result) #write the result to a new file with gene name and tissue type
in alphabetical order
handle.close()
outfile.close()
def output_TPM_HPA(input, output):
"""
Input data from Human Protien Atlas (HPA) and select transcription data for tissues and
genes of interest
Downloaded as previously summarized data files
"""
handle = open(input)
outfile = open(output, 'w')
writer = csv.writer(outfile, delimiter='\t', quotechar='"')
labels = handle.readline().strip('\n').split('\t') # column labels in first line
results = []
for row in handle:
column = row.strip('\n').split('\t') #separate each column
gene_name = column[1]
tissue_sample = column[2]
TPM = column[3]
if gene_name in sys.argv[1:]: #if gene of interest
if tissue_sample in tissues_of_interest: #if tissue type corresponds to tisses of interst
result = gene_name, tissue_sample, TPM

VIII
results.append(result) # add results to results list
for result in sorted(results):
writer.writerow(result) #write results in alphabetical order
handle.close()
outfile.close()
def compile_results(results, output):
"""
Takes list of data files generated from above functions and write all to one file.
"""
outfile = open(output, 'w')
combined_rows = []
for file in results: #iterate over files in list of resulting files
new_file = open(file)
rows = []
file_name = str(new_file)+'\n'
rows.append(file_name)
for row in new_file:
rows.append(row)
combined_rows.extend(rows) #add each individual row from file to new file
for item in combined_rows:
outfile.write(item)
new_file.close()
outfile.close()
output_TPM_GTEx('GTEx_Analysis_2016-0115_v7_RNASeQCv1.1.8_gene_tpm.tsv','GTEx_gene_mean_tpm.tsv')
output_TPM_HPA('rna_tissue.tsv', 'HPA_gene_mean_tpm.tsv')
results = ['GTEx_gene_mean_tpm.tsv', 'HPA_gene_mean_tpm.tsv'] #list of resulting files to
compile
compile_results(results, 'compiled_tissue_TPMS_Nov6.tsv') #bring all results together into
one file

IX

Appendix IV: Details for the production of all new ScFISH probes developed in this study. This includes chromosome
band, probe name, probe coordinates and size, with the forward and reverse primers used to make each probe, and the probe’s CG and
CpG content.
Chr
Band

Probe Name

2p23.1

XDH_tel9264
XDH_tel2387

3p24.3

12p12.
3

XDH_IVS30IVS27
ZNF385D_tel
640535
ZNF385D_tel
678016
FGF6_cen44
92
FGF6_IVS2

15q21.
1
15q22.
2

DUOX1_IVS
1-IVS3
TPM1_IVS5IVS8
TPM1_IVS8

15q24.
1

TPM1_tel320
0
SCAMP2_IV
S7-IVS4

Coordinates
chr2:31,545,815
-31,547,924
chr2:31,551,816
-31,554,801
chr2:31,568,769
-31,571,269
chr3:22,433,351
-22,436,333
chr3:22,470,832
-22,473,082
chr12:4,537,157
-4,538,816
chr12:4,5497764,553,205
chr15:45,422,89
0-45,424,597
chr15:63,353,57
3-63,355,980
chr15:63,357,34
6-63,360,645
chr15:63,367,31
4-63,369,607
chr15:75,142,34
9-75,145,350

Length
(bp)
2110
2986
2501
3968
2251
1660
2251
1708
2408
3300
2294
3002

Forward Primer (5` - 3`)

Reverse Primer (5` - 3`)

AAGGCAATAAAAGC
ACAGAAGACACA
GAAAACCTGATTTTG
GGACTTAGGAACA
AATCCATGCTAAAAC
CCAACTACCAAAA
CATATTTGCCTTTCA
TGCTTAGAGACCA
AACCGAGCAAATTC
CATACCAAACC
TTAATGTCTGTCTTC
CTTGCCAGTTTAT
AGCACACAATTGAA
CTGTTGATTTAGGA
GTTATTAAGCATGTC
CACCTTCCTCTTC
TTCACCCTCTGCTAT
TTATATCTTGCCT
TTTACTGTTAGGCAG
TAAGAGTTGGAGT
AGGGTTTTCAGAGCT
ACATTCCTCC
CATAAACCCTGAGGT
ACAATTCCAGAAC

AGAGCTTTCCTCTAA
GGCACATAGC
GGATTAGACTGAGG
CATTAAGGTAGTGA
TTTACTGAATTTTGT
GTCTGGCATCCTT
AATACAGGCTCTAAT
GCAGAACCATTTC
GCCTGTCACCTTCTG
TTATGTGCTC
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Appendix V: Frequency of copy number variants (CNVs) that overlap DA intervals used for scFISH probes. Data
collected from independent microarray datasets of control populations in Database of Genomic Variants (DGV) and Healthy sample
population set (Affymetrix, Inc).
DA interval
XDH_tel9264
XDH_tel2387
XDH_IVS30-IVS27
ZNF385D_tel640535
ZNF385D_tel678016
FGF6_cen4492
FGF6_IVS2
DUOX1_IVS1-IVS3
TPM1_IVS5-IVS8
TPM1_IVS8
TPM1_tel3200
SCAMP2_IVS7-IVS4
SCAMP2_IVS1
COX5A_tel20100
RBM38_tel25076
CTCFL_cen34302

Common CNVs*
DGV: 89kb gain Freq G: 0.090%, Freq L: 0%, gains: 1, losses: 0, sample size: 1109
DGV: same as above
None
None
DGV: 154 kb gain Freq G: 1.052%, Freq L: 0%, gains: 1, losses: 0, sample size: 95;
2100 kb gain Freq G: 0.003%, Freq L: 0%, gains: 1, losses: 0, sample size: 29084
DGV: gain .003-.005% G with sample size: 17,000 or 29,084
DGV: 1659 kb gain - Freq G: 0.003%, Freq L: 0%, gains: 1, losses: 0, sample size: 29084; 300 kb gain
Freq G: 0.005%, Freq L: 0%, gains: 1, losses: 0, sample size: 17421; 45 kb loss; 2100 kb LOSS Freq G:
0%, Freq L: 2.564%, gains: 0, losses: 1, sample size: 39
DGV: 30kb 1 loss (0.064%) 0 gains sample size 1557 & 2 losses (.011%) 0 gains sample size 17421//43kb
gain 1 gain (0.049%) 0 loss sample size 2026//78kb loss 1 loss (.005%) and 0 gains of 17421
samples//44kb gain 1 gain (.005%) and 0 loss of 17421 samples
DGV: 282kb gain Freq G: 1.612%, Freq L: 0%, gains: 1, losses: 0, sample size: 62; 944 kb gain Freq G:
0.003%, Freq L: 0%, gains: 1, losses: 0, sample size: 2908
None
DGV: 282kb gain Freq G: 1.612%, Freq L: 0%, gains: 1, losses: 0, sample size: 62; 944 kb gain Freq G:
0.003%, Freq L: 0%, gains: 1, losses: 0, sample size: 2908
DGV 178kb loss with 1 loss 1.052%) no gains of 95 samples
DGV: 178KB loss Freq G: 0%, Freq L: 1.052%, gains: 0, losses: 1, sample size: 95
DGV: 9; 242Kb gain Freq G: 0.005%, Freq L: 0%, gains: 1, losses: 0, sample size: 17421
DGV: 55kb Freq G: 0%, Freq L: 0.049%, gains: 0, losses: 1, sample size: 2026; Freq G: 0.003%, Freq L:
0%, gains: 1, losses: 0, sample size: 29084
DGV: 259 kb gain with 1 gain (.003%) no losses of 29084 samples

XII

PCK1_cen13036
PCK1_cen180-IVS6

one 37kb gain Healthy samples - healthy samples DGV: PMID 18451855 0ne gain by Kidd et al 2008
FISH
None

*G = gain, L= loss, Freq = frequency
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Appendix VI: Comparison between DA domain location in metaphase and
interphase TAD and sub-TAD structures 0for the XDH, FGF6, and TPM1
domains
1300

0

chr2

Scale
chr2:
predictedCT Fbind gsites

chr2

31,000,000

Scale
chr2:

31,545,000

predictedCTCFbindingsites
TADs

31,550,000

31,000,000

32,000,000

hg19

1 Mb
31,000,000

Scale
chr2:
predictedCTCFbindingsites

31,500,000

10 kb
31,555,000

32,000,000

32,500,000

hg19

31,560,000
31,565,000
predictedCTCFbindingsites

Alternating TADs
Location of scFISH probe

31,570,000

31,575,000

31,580,000

Predicted CTCF binding sites
Domain area not covered by scFISH probes

Figure 1: Localization of the XDH domain in metaphase cells relative to TAD structures
present in interphase cells. The heat map (3D Genome Browser)86 shows interaction

frequencies between chromatin within the XDH domain (indicated by yellow-light blue area
in UCSC genome browser image67) and surrounding chromatin. Alternating blue-grey and

5,000,000

light tan bars represent alternating TADs. The XDH domain localizes within a single blue-grey
TAD. Intensity of red increases with increased frequency of interaction. The scale in the top
left measures the intensity of contact frequency as the normalized number of contacts between
2 points. The XDH domain is within a section of genome with multiple levels of intra-TAD
interactions observed by multiple areas of high contact frequency at varying distances. Three
of these intra-TAD interactions over the domain are magnified in the top right corner. Predicted
CTCF binding sites87 are presented in grey-scale, with the colour darkening with increased site
binding affinity. Magnified image of DA domain (UCSC Genome Browser; GRCh37/hg19
assembly) shows full domain in light blue with yellow indicating location of hybridized
scFISH probes.
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Figure 2: Localization of the FGF6 domain in metaphase cells relative to TAD structures
present in interphase cells. The heat map (3D Genome Browser)86 shows interaction

frequencies between chromatin within the FGF6 domain (indicated by yellow-light blue area
in UCSC genome browser image67) and surrounding chromatin. Alternating blue-grey and

5,000,000

light tan bars represent alternating TADs. The FGF6 domain localizes within a single bluegrey TAD. Intensity of red increases with increased frequency of interaction. The scale in the
top left measures the intensity of contact frequency as the normalized number of contacts

between 2 points. There is a high frequency of intra-TAD interactions within and around this
domain, interacting with multiple points within the TAD. Three of these intra-TAD
interactions over the FGF6 domain are magnified in the top right corner. Predicted CTCF
binding sites87 are presented in grey-scale, with the colour darkening with increased site
binding affinity. Magnified image of DA domain (UCSC Genome Browser; GRCh37/hg19
assembly) shows full domain in light blue with yellow indicating location of hybridized
scFISH probes.

hg19

5,000,000

XV
0

Intra-TAD Interactions

chr15:62475000!64250000
2400

2400

Contact Frequency

50 kb
Scale
h
g
1
9
50 kb chr15: 63,0 ,0 63,50 ,0 64,0 ,0
Scale
chr15: 63,0 ,0 predictedCTCFb6i3n,5d0ing,0sites 64,0 ,0
0

chr15

63,000,000

0

chr15

Scale
chr15:
chr15
predictedCTCFbindingsites

Scale
chr15: 63,345,000

63,000,000

hg19

500 kb

63,000,000

63,500,000

63,000,000

63,350,000

63,355,000

hg19
10 kb
63,360,000
63,365,000
63,370,000
predictedCTCFbindingsites

64,000,000

64,000,000

64,000,000

63,375,000

63,380,000

predictedCTCFbindingsites

TADs

predictedCTCFbindingsites

Alternating TADs

Predicted CTCF binding sites

Location of scFISH probe

Domain area not covered by scFISH probes

Figure 3: Localization of the TPM1 domain in metaphase cells relative to TAD structures
present in interphase cells. The heat map (3D Genome Browser)86 shows interaction
frequencies between chromatin within the TPM1 domain (indicated by yellow-light blue area
in UCSC genome browser image67) and surrounding chromatin. Alternating blue-grey and

5,000,000

hg19

light tan bars represent alternating TADs. The TPM1 domain localizes within a single bluegrey TAD approaching the boundary with the adjacent TAD. Intensity of red increases with
increased frequency of interaction. The scale in the top left measures the intensity of contact
frequency as the normalized number of contacts between 2 points. There are some intra-TAD
interactions with sequences close to the domain, however compared to other domains, there
are fewer areas of high frequency intra-TAD interactions. Two intra-TAD interactions over the
TPM1 domain are outlined in the top right corner. Predicted CTCF binding sites87 are presented
in grey-scale, with the colour darkening with increased site binding affinity. Magnified image
of DA domain (UCSC Genome Browser; GRCh37/hg19 assembly) shows full domain in light
blue with yellow indicating location of hybridized scFISH probes.

64,0

XVI

Appendix VII: DA and EA cell count for each probe and tissue type examined
with results of significance testing between DA and EA proportions per probe
and between individuals. The number of individuals sampled for each probe investigated
is given with p value results from the two-proportion Z-test testing if there is a statistical
difference between individuals and a two-tailed binomial test with normal approximation
testing statistical difference between proportion of DA and EA cells scored overall for each
probe
Probe
Name

Tissue
Type

DA

EA

# of
individuals
tested

p-value (! = 0.05)
Two proportion
Two-tailed
Z-test between
binomial test
samples
between DA
and EA*
0.55
1.4E-04
0.75
2.3E-02
0.91
3.9E-03
0.38
2.4E-07
0.36
1.5E-06
N/A
6.7E-04
0.67
1.1E-12
0.82
3.1E-06
N/A
3.3E-04
0.80
1.5E-04
0.85
6.6E-09
0.75
2.9E-15
0.43
3.5E-07
N/A
8.8E-05
N/A
5.0E-04
0.21
2.9E-06
0.0038
8.4E-13
0.98
1.7E-04

Lymph 13
41
2
3.3_1p36
BM
32
53
2
Fibro
14
34
2
XDH_IVS Lymph
48
9
2
30-IVS27
BM
44
9
2
Fibro
21
4
1
DUOX1_I
Lymph 95 19
2
VS1-IVS3
BM
50 13
2
Fibro 32 9
1
PCK1_cen Lymph 49
18
2
180-IVS6
BM
79 21
2
Fibro 86 9
2
TPM1_tel
Lymph 55 13
2
3200
BM
23 3
1
Fibro 31 9
1
CTCFL_c
Lymph 52 14
2
en34302
BM
81 12
2
Fibro 37 11
2
+
when applicable
* in cases with more than 2 samples, 2 samples with largest number of cells selected
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